[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 505
1. Bhargava P, Hanif M, Nash C: Whole-body F-18 sodium fluoride PET-CT in a patient with renal cell carcinoma. Clin Nucl Med; 2008 Dec;33(12):894-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Whole-body F-18 sodium fluoride PET-CT in a patient with renal cell carcinoma.
  • A 59-year-old male with metastatic renal cell cancer presented with pain in the right heel.
  • Radiographs showed a large lytic lesion in the right calcaneus, suspicious for bone metastasis.
  • Intense peripheral NaF uptake was seen in the lytic lesion in the right calcaneus, which was later proven by needle biopsy to be metastasis from renal cell cancer.
  • [MeSH-major] Carcinoma, Renal Cell / radionuclide imaging. Fluorine Radioisotopes. Kidney Neoplasms / radionuclide imaging. Positron-Emission Tomography. Sodium Fluoride. Tomography, X-Ray Computed. Whole Body Imaging

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • Hazardous Substances Data Bank. SODIUM FLUORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19033802.001).
  • [ISSN] 1536-0229
  • [Journal-full-title] Clinical nuclear medicine
  • [ISO-abbreviation] Clin Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Fluorine Radioisotopes; 8ZYQ1474W7 / Sodium Fluoride
  •  go-up   go-down


2. Mrena R, Leivo I, Passador-Santos F, Hagström J, Mäkitie AA: Histopathological findings in parotid gland metastases from renal cell carcinoma. Eur Arch Otorhinolaryngol; 2008 Sep;265(9):1005-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Histopathological findings in parotid gland metastases from renal cell carcinoma.
  • Metastatic tumours involving the parotid gland arising from non-head and neck origin are rare.
  • Immunohistochemistry has improved the differential diagnosis of these lesions.
  • Current immunohistochemical markers allow the distinction between a number of potential primary tumours (e.g., lung, kidney and breast).
  • We present the clinical and histomorphological features of three renal cell carcinoma (RCC) patients presenting with a parotid mass, review the literature of various non-head and neck malignancies metastasizing to the parotid gland, and discuss their differential diagnosis.
  • Two females and one male, aged 58 to 76 years, presented with a parotid tumour of renal cell origin.
  • Two patients underwent a superficial parotidectomy and one patient an open biopsy of the parotid gland tumour.
  • Immunohistochemical stainings for vimentin, CD10 and PNRA were positive suggesting renal cell origin, which was later confirmed.
  • Clinical and radiological evaluations and diagnosis by fine needle aspiration may prove difficult partly due to the vascular nature of parotid metastasis of renal cell carcinoma.
  • Immunohistochemical staining is useful in identifying the primary tumour.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology. Parotid Neoplasms / secondary
  • [MeSH-minor] Aged. Biopsy, Fine-Needle. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Male. Middle Aged

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pathol Oncol Res. 2007;13(2):161-5 [17607380.001]
  • [Cites] Int Semin Surg Oncol. 2005 Jan 04;2(1):1 [15631629.001]
  • [Cites] Urology. 1995 Sep;46(3):406-7 [7544935.001]
  • [Cites] Histopathology. 2007 Jul;51(1):26-32 [17593078.001]
  • [Cites] J Laryngol Otol. 1990 Apr;104(4):352-4 [2370461.001]
  • [Cites] Diagn Cytopathol. 2004 Jun;30(6):401-5 [15176027.001]
  • [Cites] Head Neck. 1989 Mar-Apr;11(2):174-8 [2656583.001]
  • [Cites] Head Neck Pathol. 2007 Dec;1(2):123-31 [20614263.001]
  • [Cites] Dentomaxillofac Radiol. 2000 May;29(3):185-8 [10849547.001]
  • [Cites] J Laryngol Otol. 2001 Jun;115(6):488-90 [11429075.001]
  • [Cites] Ann Plast Surg. 2002 Feb;48(2):217-8 [11910236.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 May;99(5):554-7 [15829877.001]
  • [Cites] J Maxillofac Surg. 1984 Oct;12(5):235-6 [6593401.001]
  • [Cites] J Surg Oncol. 1976;8(2):183-90 [1263521.001]
  • [Cites] Am J Pathol. 1990 Oct;137(4):895-905 [1699423.001]
  • [Cites] Cancer. 2000 Dec 25;90(6):350-6 [11156518.001]
  • [Cites] Histopathology. 2002 May;40(5):403-39 [12010363.001]
  • [Cites] Laryngoscope. 2002 Mar;112(3):453-6 [12148853.001]
  • [Cites] Am J Surg Pathol. 2000 Feb;24(2):203-10 [10680888.001]
  • [Cites] Am J Surg Pathol. 2005 Jun;29(6):747-54 [15897741.001]
  • [Cites] Int J Urol. 2004 Oct;11(10):894-6 [15479296.001]
  • [Cites] Australas Radiol. 2004 Mar;48(1):88-92 [15027931.001]
  • [Cites] Otolaryngol Head Neck Surg. 2003 Feb;128(2):296-7 [12601333.001]
  • [Cites] J Clin Gastroenterol. 1997 Dec;25(4):698-9 [9451694.001]
  • [Cites] Int Surg. 1990 Jul-Sep;75(3):198-202 [2242976.001]
  • [Cites] Laryngoscope. 1991 Mar;101(3):245-9 [2000011.001]
  • [Cites] J Oral Maxillofac Surg. 2001 Apr;59(4):434-8 [11289175.001]
  • [Cites] Laryngoscope. 2003 Jun;113(6):1070-5 [12782825.001]
  • [Cites] BJU Int. 1999 May;83(7):861-2 [10368215.001]
  • (PMID = 18438681.001).
  • [ISSN] 0937-4477
  • [Journal-full-title] European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
  • [ISO-abbreviation] Eur Arch Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 30
  •  go-up   go-down


3. Rizzo M, Rossi RT, Bonaffini O, Scisca C, Sindoni A, Altavilla G, Benvenga S: Thyroid metastasis of clear cell renal carcinoma: Report of a case. Diagn Cytopathol; 2009 Oct;37(10):759-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Thyroid metastasis of clear cell renal carcinoma: Report of a case.
  • Renal cell carcinoma can recur many years after diagnosis and nephrectomy metastasizing even in uncommon sites, including thyroid gland.
  • Thyroid metastases are extremely rare, the most frequent site of origin are renal tumors.
  • Metastases in thyroid gland appear as painless nodules or masses, "cold" at scintiscan.
  • We report the case of a 67-year-old male patient affected by clear cell renal carcinoma, diagnosed by fine-needle aspiration cytology procedures, and treated with anticancer medical therapy, who noticed after some months a mass in the neck-thyroid region requiring deeper medical investigations.
  • By this way, thyroid fine-needle aspiration cytology reported a lesion made of malignant epithelial cells compatible with metastases of renal carcinoma (clear cell).
  • Clinical and pathological data, together with immunostaining, supported the diagnosis of metastatic clear cell renal carcinoma.
  • The diagnosis of metastatic disease, although difficult clinically and pathologically, should be suspected in patients with a clinical history of cancer, particularly in case of renal cell carcinoma, but fine-needle aspiration cytology can provide the clue for diagnosis.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology. Thyroid Neoplasms / secondary


Advertisement
4. Gillams A: Tumour ablation: current role in the liver, kidney, lung and bone. Cancer Imaging; 2008;8 Spec No A:S1-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumour ablation: current role in the liver, kidney, lung and bone.
  • There is continuing debate in most other areas but the evidence is increasing for an important role in liver metastases, renal carcinoma, inoperable lung tumours and some bone tumours.
  • [MeSH-major] Bone Neoplasms / surgery. Carcinoma, Hepatocellular / surgery. Catheter Ablation / methods. Kidney Neoplasms / surgery. Liver Neoplasms / surgery. Lung Neoplasms / surgery


5. Brenner W, Greber I, Gudejko-Thiel J, Beitz S, Schneider E, Walenta S, Peters K, Unger R, Thüroff JW: Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase. Int J Oncol; 2008 May;32(5):1125-31
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase.
  • Migration and adhesion of tumor cells are essential prerequisites for the formation of metastases in malignant diseases.
  • In order to identify a connection between PKC isoforms and tumor progression in renal cell carcinoma (RCC), the influence of PKC isoforms on cell migration, adhesion and proliferation and possible influences of the activity of integrins and focal adhesion kinase (FAK) were analyzed in RCC cells.
  • These findings show a critical role of PKCdelta in the regulation of tumor cell migration, which seems to be caused by affecting the expression and activity of beta1 integrins and FAK.
  • These results can provide a basis for new strategies in preventing metastases of renal cell carcinoma.
  • [MeSH-major] Antigens, CD29 / metabolism. Carcinoma, Renal Cell / metabolism. Cell Movement. Focal Adhesion Protein-Tyrosine Kinases / metabolism. Kidney Neoplasms / metabolism. Protein Kinase C-delta / metabolism. Signal Transduction
  • [MeSH-minor] Cell Adhesion. Cell Line, Tumor. Cell Proliferation. Dose-Response Relationship, Drug. Humans. Neoplasm Metastasis. Phosphorylation. Protein Kinase Inhibitors / pharmacology

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18425341.001).
  • [ISSN] 1019-6439
  • [Journal-full-title] International journal of oncology
  • [ISO-abbreviation] Int. J. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Chemical-registry-number] 0 / Antigens, CD29; 0 / Protein Kinase Inhibitors; EC 2.7.10.2 / Focal Adhesion Protein-Tyrosine Kinases; EC 2.7.11.13 / Protein Kinase C-delta
  •  go-up   go-down


6. Pompeo AC, Kanashiro H, Silva MN: Renal cell carcinoma presenting as a cervical mass. Int Braz J Urol; 2005 Mar-Apr;31(2):151-2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Renal cell carcinoma presenting as a cervical mass.
  • The authors report a case of a 60-year-old woman presenting with a renal cell carcinoma in which the first sign leading to its diagnosis was a cervical metastasis, an uncommon site of distant disease in renal neoplasms.
  • After laboratory and radiological evaluation, the cervical mass was excised, and the microscopic and immunohistochemical patterns suggested the possibility of a metastatic renal cell carcinoma.
  • Computerized tomography of the abdomen showed a solid, 4 cm left renal mass.
  • A radical left nephrectomy was performed, and the histology confirmed the suspected diagnosis.
  • It seems that head and neck metastasis of renal cell carcinoma should preferentially be treated with surgical excision because of the associated morbidity and quality-of-life issues.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Head and Neck Neoplasms / secondary. Kidney Neoplasms / pathology

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15877835.001).
  • [ISSN] 1677-5538
  • [Journal-full-title] International braz j urol : official journal of the Brazilian Society of Urology
  • [ISO-abbreviation] Int Braz J Urol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


7. Assouad J, Riquet M, Berna P, Danel C: Intrapulmonary lymph node metastasis and renal cell carcinoma. Eur J Cardiothorac Surg; 2007 Jan;31(1):132-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intrapulmonary lymph node metastasis and renal cell carcinoma.
  • Intrapulmonary lymph node metastasis occuring after nephrectomy for renal cell carcinoma is a particular recurrence modality.
  • Surgery confirmed the diagnosis and demonstrated station 7 minimal metastases and positive pleural lavage cytology in both patients.
  • The first patient survived 2 years and the second was alive disease free at 33 months follow-up.
  • Such metastases probably originate from the thoracic duct.
  • Resection confirms the diagnosis and may be part of the treatment.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Kidney Neoplasms / surgery. Lung Neoplasms / secondary
  • [MeSH-minor] Adult. Humans. Lymphatic Metastasis. Male. Middle Aged. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17118670.001).
  • [ISSN] 1010-7940
  • [Journal-full-title] European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • [ISO-abbreviation] Eur J Cardiothorac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


8. Masuda N, Shiraishi Y, Okubo K, Okada T, Segawa T, Takada M, Kawakita M: [A case report of renal cell carcinoma with metastatic intraductal tumor thrombus of the common bile duct]. Hinyokika Kiyo; 2009 Feb;55(2):99-102
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case report of renal cell carcinoma with metastatic intraductal tumor thrombus of the common bile duct].
  • We present a case of liver metastasis of renal cell carcinoma (RCC) presenting as an intraductal tumor thrombus of the common bile duct.
  • He had undergone right nephrectomy for RCC 8 years previously, and had been administered interferon alfa for lung, bone, and liver metastases for these 3 years.
  • Abdominal enhanced computerized tomography (CT) disclosed the progression of liver metastasis to the common bile duct and the dilated bilateral bile ducts.
  • Endoscopic retrograde cholangiopancreatography (ERCP) revealed a smooth filling defect in an upper portion of the common bile duct, suggesting an intraductal RCC tumor thrombus of the common bile duct.
  • Liver metastasis of RCC proceeding to the common bile duct is extremely rare, and this is the 8th case.
  • We should be aware of the fact that metastatic intraductal tumor thrombus of the common bile duct can cause obstructive jaundice.
  • [MeSH-major] Carcinoma, Renal Cell / pathology. Common Bile Duct / pathology. Kidney Neoplasms / pathology. Neoplastic Cells, Circulating / pathology
  • [MeSH-minor] Humans. Jaundice, Obstructive / etiology. Liver Neoplasms / secondary. Male. Middle Aged

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19301615.001).
  • [ISSN] 0018-1994
  • [Journal-full-title] Hinyokika kiyo. Acta urologica Japonica
  • [ISO-abbreviation] Hinyokika Kiyo
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 16
  •  go-up   go-down


9. Weber K, Doucet M, Kominsky S: Renal cell carcinoma bone metastasis--elucidating the molecular targets. Cancer Metastasis Rev; 2007 Dec;26(3-4):691-704
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Renal cell carcinoma bone metastasis--elucidating the molecular targets.
  • The development of bone metastasis from renal cell carcinoma (RCC) signals a transition to a terminal state for the patient with previously isolated disease.
  • These patients may suffer the morbidity of severe, persistent pain, pathologic fractures, and spinal compression from vertebral metastasis before they succumb to their cancer.
  • Although recent advancements have been made in the understanding of breast and prostate bone metastasis, there has been less knowledge in the area of metastatic RCC to the skeleton.
  • This particular cancer in bone remains relatively resistant to standard forms of treatment such as radiation and chemotherapy.
  • A better understanding of the biology of RCC bone metastasis is critically needed in order to improve treatment.
  • [MeSH-major] Bone Neoplasms / drug therapy. Bone Neoplasms / secondary. Carcinoma, Renal Cell / pathology. Kidney Neoplasms / pathology


10. Sakamoto A, Yoshida T, Matsuura S, Tanaka K, Matsuda S, Oda Y, Hori Y, Yokomizo A, Iwamoto Y: Metastasis to the gluteus maximus muscle from renal cell carcinoma with special emphasis on MRI features. World J Surg Oncol; 2007;5:88
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasis to the gluteus maximus muscle from renal cell carcinoma with special emphasis on MRI features.
  • BACKGROUND: The skeletal muscle is an unusual site for metastasis from renal cell carcinoma (RCC).
  • Metastatic RCC must be differentiated from benign primary soft-tissue tumors because aggressive surgical resection is necessary.
  • CASE PRESENTATION: We present the case of a 65-year-old man with metastatic RCC in the gluteus maximus muscle (3.8 cm in diameter) found on enhanced computed tomography (CT) 6 years after nephrectomy.
  • Because the growth of the lesion was slow, benign tumor was a differential diagnosis.
  • Therefore, under a diagnosis of metastatic RCC, the lesion was resected together with the surrounding skeletal muscle.
  • The histology was confirmed to be metastatic RCC.
  • CONCLUSION: MRI features of metastatic RCC may be beneficial in differentiating it from primary soft-tissue tumor.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJR Am J Roentgenol. 2000 Jun;174(6):1623-8 [10845496.001]
  • [Cites] Skeletal Radiol. 2000 Apr;29(4):187-95 [10855466.001]
  • [Cites] J Orthop Sci. 2001;6(2):189-92 [11484108.001]
  • [Cites] Acta Chir Belg. 2002 Oct;102(5):351-2 [12471771.001]
  • [Cites] J Ultrasound Med. 2005 Oct;24(10):1419-23; quiz 1424-5 [16179627.001]
  • [Cites] Eur Urol. 1991;20(2):167-9 [1752278.001]
  • [Cites] J Urol. 1996 Jul;156(1):173 [8648786.001]
  • [Cites] Tumori. 1990 Aug 31;76(4):407-9 [2399572.001]
  • [Cites] Cancer. 1973 Nov;32(5):1030-42 [4131758.001]
  • [Cites] J Urol. 1981 Jul;126(1):17-23 [7253072.001]
  • [Cites] Skeletal Radiol. 1995 May;24(4):267-70 [7644939.001]
  • [Cites] Scand J Urol Nephrol. 1993;27(1):143-4 [8493466.001]
  • [Cites] Urol Clin North Am. 1993 May;20(2):247-62 [8493748.001]
  • [Cites] Int Surg. 1990 Jul-Sep;75(3):198-202 [2242976.001]
  • (PMID = 17683570.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1976113
  •  go-up   go-down


11. Bandiera A, Melloni G, Freschi M, Giovanardi M, Carretta A, Borri A, Ciriaco P, Zannini P: Prognostic factors and analysis of S100a4 protein in resected pulmonary metastases from renal cell carcinoma. World J Surg; 2009 Jul;33(7):1414-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic factors and analysis of S100a4 protein in resected pulmonary metastases from renal cell carcinoma.
  • BACKGROUND: This study analyzes our experience with pulmonary resection for metastases from renal cell carcinoma.
  • The goals were to search for factors influencing prognosis and to investigate the presence and the prognostic value of S100A4 protein in lung metastases and corresponding primary renal tumors.
  • METHODS: Sixty-five patients underwent surgical resection for renal and pulmonary lesions between 1992 and 2007.
  • S100A4 protein expression was immunohistochemically examined in the peritumoral infiltrate of 64 lesions (32 metastases and the 32 corresponding primary carcinomas).
  • Univariate analysis revealed that surgical radicality (p = 0.0039) and stratification into groups according to the International Registry of Lung Metastases classification (p = 0.0137) were prognostic factors.
  • All metastases and the corresponding primary carcinomas expressed S100A4 protein.
  • Twenty-one metastases (66%) had weak expression and 11 (34%) had strong expression.
  • CONCLUSIONS: Pulmonary resection in metastatic renal cell carcinoma results in long-term survival.
  • Complete resection and stratification into groups according to the International Registry of Lung Metastases classification were prognostic factors.
  • If confirmed in larger studies this finding could be used to schedule adjuvant treatments in patients undergoing nephrectomy for renal cell carcinoma.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Carcinoma, Renal Cell / surgery. Kidney Neoplasms / surgery. Lung Neoplasms / secondary. Lung Neoplasms / surgery. S100 Proteins / metabolism


12. Powis M: Neonatal renal tumours. Early Hum Dev; 2010 Oct;86(10):607-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neonatal renal tumours.
  • Neonatal renal tumours are rare, with only 7% of all neonatal tumours arising from the kidney.
  • Mesoblastic nephroma is the most common tumour to be found at this age, but Wilms' tumour and other malignant and benign tumours occur.
  • Given the low malignant potential of these tumours, treatment is by radical nephroureterctomy, except in cases with bilateral disease or syndromic patients with a high incidence of metachronous tumours.
  • Survival is generally excellent for all tumour types in this age group, the exception being malignant rhabdoid tumour of the kidney which may have metastases at presentation.
  • [MeSH-major] Kidney Neoplasms / diagnosis. Nephroma, Mesoblastic / diagnosis. Wilms Tumor / diagnosis
  • [MeSH-minor] Anatomy, Cross-Sectional. Diagnosis, Differential. Genetic Predisposition to Disease. Humans. Imaging, Three-Dimensional. Infant, Newborn. Neuroblastoma / diagnosis. Practice Guidelines as Topic. Risk Factors

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Wilms Tumor.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.
  • (PMID = 20888153.001).
  • [ISSN] 1872-6232
  • [Journal-full-title] Early human development
  • [ISO-abbreviation] Early Hum. Dev.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Ireland
  •  go-up   go-down


13. Thelen A, Jonas S, Benckert C, Lopez-Hänninen E, Rudolph B, Neumann U, Neuhaus P: Liver resection for metastases from renal cell carcinoma. World J Surg; 2007 Apr;31(4):802-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Liver resection for metastases from renal cell carcinoma.
  • BACKGROUND: This study was conducted to evaluate the safety and efficacy of liver resection in patients with hepatic metastases from renal cell carcinoma and to identify selection criteria for patients suitable for resection.
  • METHODS: Between January 1988 and March 2006, 31 patients underwent liver resection for metastases from renal cell carcinoma.
  • Patient, tumor, and operative parameters were analyzed for their influence on long-term survival.
  • In the univariate analysis, site of the primary tumor (P = 0.013), disease-free interval (P = 0.012), and resection margins (P = 0.008) showed significant influence on long-term survival.
  • CONCLUSIONS: Liver resection is effective and safe in the treatment of patients with hepatic metastases from renal cell carcinoma and offers the chance of long-term survival and cure.
  • [MeSH-major] Carcinoma, Renal Cell / surgery. Hepatectomy / methods. Kidney Neoplasms / pathology. Liver Neoplasms / surgery


14. Cichoń S, Anielski R, Konturek A, Barczyński M, Cichoń W: Metastases to the thyroid gland: seventeen cases operated on in a single clinical center. Langenbecks Arch Surg; 2006 Nov;391(6):581-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastases to the thyroid gland: seventeen cases operated on in a single clinical center.
  • BACKGROUND AND AIMS: In spite of its rich vasculature, the thyroid gland is rarely the site of metastatic disease.
  • The incidence of such metastases differs depending on the type of the analyzed material.
  • In clinical papers, the incidence is low and, according to various sources, amounts to 2-3% of all malignant tumors of the thyroid.
  • Most commonly, the primary tumor is located in the breast, bronchi, gastrointestinal system, (the colon, esophagus, or stomach) and kidneys.
  • Usually, metastatic thyroid disease is identified upon autopsy, and only sporadic cases are encountered in clinical material.
  • The authors present their experience in treating metastatic disease involving the thyroid gland based on the analysis of their clinical material consisting of patients operated on in a single center.
  • MATERIALS AND METHODS: Seventeen patients presented with metastatic tumors of the thyroid.
  • RESULTS: In 13 patients, the primary lesion was a clear cell carcinoma of the kidney, in one breast cancer, in another one uterine carcinoma.
  • Of this group, seven are still alive, including five individuals with metastases of renal carcinomas, but without recurrent disease.
  • CONCLUSIONS: The most commonly clinically detected and treated surgically metastatic lesion of the thyroid gland is clear cell cancer of the kidney.
  • In cases of renal cancer metastases to the thyroid gland, a total thyroidectomy seems to be warranted, although it does not affect the survival time.
  • [MeSH-major] Breast Neoplasms / pathology. Carcinoma, Renal Cell / secondary. Genital Neoplasms, Female / pathology. Kidney Neoplasms / pathology. Thyroid Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Surg Oncol. 1994 Jul;1(4):345-52 [7850534.001]
  • [Cites] Acta Otorhinolaryngol Ital. 1991 Jul-Aug;11(4):429-35 [1792897.001]
  • [Cites] Br J Urol. 1983 Apr;55(2):166-70 [6839087.001]
  • [Cites] Chirurg. 2003 Aug;74(8):768-74 [12928802.001]
  • [Cites] Ann Acad Med Singapore. 2004 Jan;33(1):100-2 [15008573.001]
  • [Cites] Radiat Med. 1991 Sep-Oct;9(5):167-9 [1771245.001]
  • [Cites] Thyroid. 1998 Feb;8(2):149-53 [9510123.001]
  • [Cites] Endocr J. 2004 Aug;51(4):445-8 [15351802.001]
  • [Cites] Ear Nose Throat J. 1996 Sep;75(9):620-22 [8870369.001]
  • [Cites] Minerva Chir. 1994 Mar;49(3):223-7 [8028737.001]
  • [Cites] Langenbecks Arch Chir. 1987;370(1):25-35 [3573876.001]
  • [Cites] World J Surg. 1999 Feb;23(2):177-80; discussion 181 [9880428.001]
  • [Cites] Presse Med. 1995 Oct 14;24(30):1386-8 [8545316.001]
  • [Cites] Yonsei Med J. 2001 Aug;42(4):411-7 [11519083.001]
  • [Cites] Eur J Surg Oncol. 2004 Aug;30(6):583-8 [15256229.001]
  • [Cites] Cancer. 2002 Nov 1;95(9):1869-78 [12404280.001]
  • [Cites] Przegl Lek. 2000;57(3):157-9 [10909286.001]
  • [Cites] Arch Pathol Lab Med. 1998 Jan;122(1):37-41 [9448014.001]
  • [Cites] J Endocrinol Invest. 2003 Jun;26(6):560-3 [12952372.001]
  • [Cites] Ann Endocrinol (Paris). 2004 May;65(3):205-8 [15277977.001]
  • [Cites] Cancer. 1997 Feb 1;79(3):574-8 [9028370.001]
  • [Cites] Acta Pathol Microbiol Scand Suppl. 1977;(260):1-235 [269649.001]
  • [Cites] Eur J Intern Med. 2003 Oct;14(6):377-379 [14769497.001]
  • [Cites] J Comput Assist Tomogr. 2000 Jul-Aug;24(4):539-45 [10966183.001]
  • [Cites] Thyroid. 1994 Fall;4(3):297-300 [7833666.001]
  • (PMID = 16983577.001).
  • [ISSN] 1435-2443
  • [Journal-full-title] Langenbeck's archives of surgery
  • [ISO-abbreviation] Langenbecks Arch Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


15. Fujiwara Y, Kiura K, Tabata M, Takigawa N, Hotta K, Umemura S, Omori M, Gemba K, Ueoka H, Tanimoto M: Remarkable shrinkage of sarcomatoid renal cell carcinoma with single-agent gemcitabine. Anticancer Drugs; 2008 Apr;19(4):431-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Remarkable shrinkage of sarcomatoid renal cell carcinoma with single-agent gemcitabine.
  • Computed tomography showed a tumor in the left kidney and metastases in the left gluteus maximus muscle and lung.
  • The pathological diagnosis of a biopsy specimen obtained from a metastatic lesion in the left gluteus maximus muscle was sarcomatoid renal cell carcinoma.
  • This seriously ill patient suffering from advanced sarcomatoid renal cell carcinoma was treated with single-agent gemcitabine, resulting in symptom relief and a dramatic improvement in his status; all of the tumors had regressed significantly by the 11th dose of gemcitabine.
  • These findings indicate that single-agent gemcitabine is one of the few chemotherapeutic agents effective for palliation in patients with sarcomatoid renal cell carcinoma, even those with poor performance status.
  • [MeSH-major] Antimetabolites, Antineoplastic / therapeutic use. Carcinoma, Renal Cell / drug therapy. Deoxycytidine / analogs & derivatives. Kidney Neoplasms / drug therapy
  • [MeSH-minor] Buttocks / pathology. Humans. Lung Neoplasms / radiography. Lung Neoplasms / secondary. Male. Middle Aged. Muscle Neoplasms / secondary. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18454054.001).
  • [ISSN] 0959-4973
  • [Journal-full-title] Anti-cancer drugs
  • [ISO-abbreviation] Anticancer Drugs
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antimetabolites, Antineoplastic; 0W860991D6 / Deoxycytidine; B76N6SBZ8R / gemcitabine
  •  go-up   go-down


16. Haffner J, Morel JF, Maunoury V, Caty A, Biserte J, Villers A: [Gastric or duodenal metastases from clear cell renal cell carcinoma. Report of two cases and review of the literature]. Prog Urol; 2007 Nov;17(7):1305-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Gastric or duodenal metastases from clear cell renal cell carcinoma. Report of two cases and review of the literature].
  • [Transliterated title] Métastases gastriques et duodénales de cancer du rein à cellules conventionnelles.
  • INTRODUCTION: Gastric or duodenal metastases from clear cell renal cell carcinoma are exceptional.
  • According to autopsy series, the incidence of gastrointestinal metastases is 0.06 to 4% for all cancers and 0.2 and 0.7% for renal cancers.
  • OBJECTIVE: To define the diagnostic and therapeutic management of these rare sites in the light of 2 cases of gastric metastases from renal cancer seen in our institution and a review of the literature.
  • RESULTS: These two patients with gastric or duodenal metastases from renal cancer can be added to the 15 cases found in the literature.
  • These 17 cases consisted of 5 cases of duodenal metastases and 12 cases of gastric metastases and were described in 14 articles (2 articles comprised 2 and 3 cases, respectively).
  • Metastases were the presenting sign of the cancer in 3 cases or occurred during follow-up after nephrectomy in 14 cases after a mean of 6.6 years (range: 2 years-14 years).
  • The mean number of metastatic sites was 2.5 (range: 1-5).
  • Gastroscopy established the diagnosis and allowed biopsies and control of acute bleeding.
  • For patients with a solitary metastasis and in good general condition, gastrectomy was performed as complementary treatment.
  • For patients with multiple or inoperable metastases, treatment consisted of either endoscopic resection, embolization of the metastasis, or immunotherapy.
  • CONCLUSION: Surgical resection of the metastasis is the preferred treatment in the case of a solitary metastasis and absence of contraindication related to the general state.
  • In the other cases, endoscopic resection or embolization of the metastasis can be proposed, with or without systemic immunotherapy.
  • The place of targeted anti-tumour treatments such as anti-angiogenic drugs has not been evaluated
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Duodenal Neoplasms / secondary. Kidney Neoplasms / pathology. Stomach Neoplasms / secondary


17. Jacob J, Chargari C, Bauduceau O, Fayolle M, Ceccaldi B, Prat F, Le Moulec S, Vedrine L: Pancreatic metastasis from prostate cancer. Case Rep Med; 2010;2010:826273
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pancreatic metastasis from prostate cancer.
  • The pancreas is an unusual location for metastases from other primary cancers.
  • Rarely, pancreatic metastases from kidney or colorectal cancers have been reported.
  • We report an exceptional case of pancreatic metastasis from prostate cancer.
  • Differences in management between primary and secondary pancreatic tumors make recognition of metastases to the pancreas an objective of first importance.
  • Knowledge of unusual locations for metastatic spread will reduce diagnostic delay and lead to a timely delivery of an appropriate treatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pancreatology. 2004;4(6):509-20 [15316227.001]
  • [Cites] Br J Radiol. 1998 Nov;71(851):1208-14 [10434919.001]
  • [Cites] Br J Radiol. 1999 Oct;72(862):933-41 [10673942.001]
  • [Cites] Diagn Cytopathol. 2004 Oct;31(4):216-20 [15452907.001]
  • [Cites] Arch Surg. 1998 Apr;133(4):413-7; discussion 418-9 [9565122.001]
  • (PMID = 20508841.001).
  • [ISSN] 1687-9635
  • [Journal-full-title] Case reports in medicine
  • [ISO-abbreviation] Case Rep Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2874928
  •  go-up   go-down


18. Taccone FS, Salmon I, Marechal R, Blecic SA: Paraneoplastic vasculitis of central nervous system presenting as recurrent cryptogenic stroke. Int J Clin Oncol; 2007 Apr;12(2):155-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report the case of paraneoplastic vasculitis of the central nervous system associated with breast cancer.
  • Magnetic resonance imaging (MRI) showed cerebral and medullary cryptogenic lesions, and a diagnosis of encephalomyelitis of unknown origin was made.
  • The previous diagnosis was then changed, because a poorly differentiated invasive lobular breast cancer was discovered.
  • Thoracic and abdominal computed tomography (CT) scans diagnosed pulmonary, pericardial, adrenal, and renal metastases.
  • Because MRI findings did not fit with the diagnosis of brain metastases, a CT-guided cerebral biopsy was performed, and she was eventually diagnosed with paraneoplastic vasculitis of the central nervous system.
  • [MeSH-minor] Adrenal Gland Neoplasms / secondary. Breast Neoplasms / pathology. Carcinoma, Lobular / pathology. Epilepsy / etiology. Fatal Outcome. Female. Heart Neoplasms / secondary. Humans. Kidney Neoplasms / secondary. Lung Neoplasms / secondary. Magnetic Resonance Imaging. Middle Aged. Pericardium / pathology. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Vasculitis.
  • MedlinePlus Health Information. consumer health - Stroke.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arthritis Care Res. 2000 Dec;13(6):417-23 [14635319.001]
  • [Cites] J Rheumatol. 1990 Nov;17(11):1458-62 [2273485.001]
  • [Cites] Neurosurgery. 2000 Jun;46(6):1504-8; discussion 1508-10 [10834654.001]
  • [Cites] Rev Neurol (Paris). 1992;148(11):663-71 [1303555.001]
  • [Cites] J Neurol. 2001 Jun;248(6):451-68 [11499635.001]
  • [Cites] Ann Pathol. 2002 Jun;22(3):194-205 [12410102.001]
  • [Cites] Curr Opin Neurol. 1998 Jun;11(3):241-6 [9642543.001]
  • [Cites] Angiology. 2003 Jan;54(1):11-7 [12593491.001]
  • [Cites] Neurology. 1989 Apr;39(4):522-6 [2538778.001]
  • [Cites] N Engl J Med. 2000 Mar 30;342(13):957-65 [10738055.001]
  • [Cites] Semin Neurol. 2003 Jun;23(2):215-24 [12894387.001]
  • [Cites] Medicine (Baltimore). 1985 Jan;64(1):16-35 [3965856.001]
  • (PMID = 17443285.001).
  • [ISSN] 1341-9625
  • [Journal-full-title] International journal of clinical oncology
  • [ISO-abbreviation] Int. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


19. Ricketts R, Tamboli P, Czerniak B, Guo CC: Tumor-to-tumor metastasis: report of 2 cases of metastatic carcinoma to angiomyolipoma of the kidney. Arch Pathol Lab Med; 2008 Jun;132(6):1016-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumor-to-tumor metastasis: report of 2 cases of metastatic carcinoma to angiomyolipoma of the kidney.
  • Tumor-to-tumor metastasis is a rare phenomenon.
  • Renal cell carcinoma is the most common recipient of tumor-to-tumor metastasis in malignant tumors.
  • However, renal angiomyolipoma has not been reported to be a recipient.
  • Here we report 2 cases of tumor-to-tumor metastasis to renal angiomyolipoma.
  • In one case, the donor tumor originated from neuroendocrine carcinoma of the pancreas, and in the other case the donor tumor was from adenocarcinoma of the lung.
  • The donor tumors showed morphologic features that did not easily fit into renal angiomyolipoma, and they also demonstrated patterns of immunoreactivity consistent with the primary tumors rather than with renal angiomyolipoma.
  • To our knowledge, these are the first reported cases of tumor-to-tumor metastasis to renal angiomyolipoma.
  • An awareness of this phenomenon is important to avoid an incorrect diagnosis when encountering unusual morphologic features in renal angiomyolipoma.
  • [MeSH-major] Angiomyolipoma / pathology. Carcinoma / pathology. Kidney Neoplasms / pathology. Neoplasms, Multiple Primary / pathology

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18517262.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


20. Nakajima T, Yasufuku K, Wong M, Iyoda A, Suzuki M, Sekine Y, Shibuya K, Hiroshima K, Iizasa T, Fujisawa T: Histological diagnosis of mediastinal lymph node metastases from renal cell carcinoma by endobronchial ultrasound-guided transbronchial needle aspiration. Respirology; 2007 Mar;12(2):302-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Histological diagnosis of mediastinal lymph node metastases from renal cell carcinoma by endobronchial ultrasound-guided transbronchial needle aspiration.
  • Different radiological modalities are available for the detection of mediastinal lymph node metastases such as multidetector helical CT, PET-scan and PET-CT.
  • However, tissue sampling is required for a firm diagnosis.
  • This method is appropriate not only for cytodiagnosis but also for histological diagnosis.
  • This current study reports a case of mediastinal lymph node metastases from renal cell carcinoma successfully diagnosed histologically by endobronchial ultrasound-guided transbronchial needle aspiration.
  • [MeSH-major] Carcinoma, Renal Cell / ultrasonography. Endosonography. Kidney Neoplasms / pathology. Lymph Nodes / pathology
  • [MeSH-minor] Biopsy, Fine-Needle / methods. Bronchoscopy. Diagnosis, Differential. Humans. Lymphatic Metastasis. Male. Mediastinum. Middle Aged

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17298469.001).
  • [ISSN] 1323-7799
  • [Journal-full-title] Respirology (Carlton, Vic.)
  • [ISO-abbreviation] Respirology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


21. Malhotra G, Asopa R, Rajan MG: Renal metastases from thyroid carcinoma. Thyroid; 2010 Nov;20(11):1321; author reply 321-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Renal metastases from thyroid carcinoma.
  • [MeSH-major] Carcinoma / secondary. Kidney Neoplasms / secondary. Thyroid Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Thyroid. 2010 Apr;20(4):429-33 [20373987.001]
  • (PMID = 21062198.001).
  • [ISSN] 1557-9077
  • [Journal-full-title] Thyroid : official journal of the American Thyroid Association
  • [ISO-abbreviation] Thyroid
  • [Language] eng
  • [Publication-type] Comment; Letter
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Iodine Radioisotopes; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


22. Wada Y, Kuwahara T, Uyama E, Nakanishi J, Takahashi W, Honda J, Kikukawa H, Jinnouchi Y, Ueda S: Neurologic toxicity associated with interferon alpha therapy for renal cell carcinoma. Int J Urol; 2006 Jun;13(6):811-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neurologic toxicity associated with interferon alpha therapy for renal cell carcinoma.
  • A 67-year-old man received interferon alpha (IFN alpha) therapy for lung metastases of renal cell carcinoma (RCC).
  • Multiple pulmonary metastases disappeared completely.
  • [MeSH-major] Interferon-alpha / adverse effects. Kidney Neoplasms / complications. Lung Neoplasms / complications. Nervous System Diseases / chemically induced
  • [MeSH-minor] Aged. Carcinoma, Renal Cell. Humans. Male. Remission Induction


23. Lee HJ, Park JI, Lim BH, Seo JW, Kang EM, Lee BU, Kim YJ: Left ventricular metastasis from renal cell carcinoma causing left ventricular outflow tract obstruction. Korean Circ J; 2010 Aug;40(8):410-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Left ventricular metastasis from renal cell carcinoma causing left ventricular outflow tract obstruction.
  • Most cases of cardiac metastasis from renal cell carcinoma (RCC) involve the vena cava or right atrium.
  • Left ventricular metastases from RCC without involving the vena cava or right atrium are extremely rare.
  • Herein we report a case of RCC with left ventricular metastasis causing left ventricular outflow obstruction (LVOT).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20830256.001).
  • [ISSN] 1738-5555
  • [Journal-full-title] Korean circulation journal
  • [ISO-abbreviation] Korean Circ J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2933467
  • [Keywords] NOTNLM ; Echocardiography / Heart neoplasms / Heart ventricles / Metastasis / Renal cell carcinoma
  •  go-up   go-down


24. Kato D, Abe Y, Nishihara K, Katsumoto F, Tamae K, Mitsuyama S: Pancreatic metastasis from renal cell carcinoma 13 years after a nephrectomy: report of a case. Int Surg; 2007 Jul-Aug;92(4):230-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pancreatic metastasis from renal cell carcinoma 13 years after a nephrectomy: report of a case.
  • The pancreas is an uncommon site of metastasis from renal cell carcinoma.
  • We herein present the case of a 59-year-old woman in whom pancreatic metastasis from renal cell carcinoma, found 13 years after undergoing a nephrectomy, was successfully resected and who has since showed no evidence of recurrence or metastasis.
  • The efficacy of performing a pancreatectomy for metastatic renal cell carcinoma is also presented.
  • We recommend careful long-term follow-up in patients with a history of renal cell carcinoma.
  • Imaging modalities should be used during the routine follow-up to detect any asymptomatic metastases at an early stage.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology. Pancreatic Neoplasms / secondary


25. Sakamoto LH, Mendes W, Pecora M, Andrade RG, Begnani MD, de Camargo B: Bilateral renal metastases from osteosarcoma: A case report and review of the literature. J Pediatr Hematol Oncol; 2006 Sep;28(9):618-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bilateral renal metastases from osteosarcoma: A case report and review of the literature.
  • We report a young adult with OS who developed late bilateral renal relapse.
  • Late recurrences to the kidneys have a more aggressive clinical behavior and poor prognosis documented by 15 cases of OS metastastic to the kidney in the literature.
  • [MeSH-major] Bone Neoplasms / pathology. Kidney Neoplasms / secondary. Osteosarcoma / secondary
  • [MeSH-minor] Adult. Combined Modality Therapy. Humans. Lung Neoplasms / secondary. Lung Neoplasms / therapy. Male. Tibia / pathology


26. Liu J, Costello PC, Pham NA, Pintillie M, Jabali M, Sanghera J, Tsao MS, Johnston MR: Integrin-linked kinase inhibitor KP-392 demonstrates clinical benefits in an orthotopic human non-small cell lung cancer model. J Thorac Oncol; 2006 Oct;1(8):771-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Integrin-linked kinase inhibitor KP-392 demonstrates clinical benefits in an orthotopic human non-small cell lung cancer model.
  • INTRODUCTION: The overexpression of integrin-linked kinase (ILK) has been implicated in the promotion of tumor invasion and metastasis.
  • In vivo, the effect of KP-392 was investigated in a metastatic H460 orthotopic lung cancer model.
  • In group II, tumor growth and metastasis were evaluated by sacrificing one animal from each treatment when a control animal died.
  • Although KP-392 alone did not impact the incidence of metastasis, in combination with cisplatin a consistent trend of inhibition was seen for metastases in the kidney, bone, and the contralateral lung.
  • KP-392 demonstrated increased tumor necrosis and decreased nuclear phospho-protein kinase/Akt but did not change the levels of phospho-extracellular signal-regulated kinase 1/2.
  • CONCLUSIONS: ILK inhibitor does not enhance the toxicity of standard chemotherapy and may have a beneficial therapeutic effect in lung cancer.
  • [MeSH-minor] Animals. Cell Line, Tumor. Cisplatin / administration & dosage. Humans. Lymphatic Metastasis. Neoplasm Transplantation. Rats. Rats, Nude


27. Sin AH, Cardenas RJ, Vannemreddy P, Nanda A: Gamma Knife stereotactic radiosurgery for intracranial metastases from conventionally radioresistant primary cancers: outcome analysis of survival and control of brain disease. South Med J; 2009 Jan;102(1):42-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Gamma Knife stereotactic radiosurgery for intracranial metastases from conventionally radioresistant primary cancers: outcome analysis of survival and control of brain disease.
  • OBJECTIVE: The aim of this study was to analyze our experience with stereotactic radiosurgery in the management of patients with brain metastases from radioresistant primary cancers.
  • RESULTS: Over a 48-month period, 31 patients received radiosurgery for brain metastases from renal cell carcinoma (n = 7), malignant melanoma (n = 14), or colon carcinoma (n = 10) at our institution.
  • Six deaths (30%) resulted from progressive brain disease while 14 patients died from progressive primary and/or extracranial metastatic disease.
  • The overall survival was directly related to tumor control time (P <0.001) and inversely to the number of metastases (P = 0.031).
  • CONCLUSION: Gamma Knife stereotactic radiosurgery for intracranial metastases from conventionally radioresistant primary cancers is a safe and effective method to provide better local control of the brain disease and improve survival time.
  • [MeSH-major] Brain Neoplasms / secondary. Brain Neoplasms / surgery. Radiosurgery / instrumentation

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19077767.001).
  • [ISSN] 1541-8243
  • [Journal-full-title] Southern medical journal
  • [ISO-abbreviation] South. Med. J.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


28. Testini M, Lissidini G, Gurrado A, Lastilla G, Ianora AS, Fiorella R: Acute airway failure secondary to thyroid metastasis from renal carcinoma. World J Surg Oncol; 2008;6:14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acute airway failure secondary to thyroid metastasis from renal carcinoma.
  • BACKGROUND: Secondary involvement of the thyroid gland by malignant metastases is uncommon.
  • Renal cell carcinoma is a tumour that metastasizes diffusely and in an unpredictable manner.
  • A right radical nephrectomy for renal cell carcinoma was performed 8 years previously.
  • Histological examination confirmed the diagnosis of thyroid metastasis from renal cell carcinoma.
  • CONCLUSION: A literature review regarding emergency treatment for acute respiratory compromise resulting from secondary thyroid tumours was undertaken.
  • Only two cases of metastatic colon cancer and one case of metastatic meningioma requiring emergency thyroidectomy for acute respiratory failure are reported in the literature.
  • This appears to be the first case of emergency surgery performed for acute respiratory compromise due to thyroid metastasis from renal cell carcinoma.
  • [MeSH-major] Airway Obstruction / etiology. Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology. Thyroid Neoplasms / complications. Thyroid Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Choking.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Microsurgery. 2004;24(1):39-42 [14748023.001]
  • [Cites] Del Med J. 2003 Aug;75(8):285-8 [12971227.001]
  • [Cites] Rev Laryngol Otol Rhinol (Bord). 1996;117(3):237-9 [9102733.001]
  • [Cites] Endocr Pract. 2001 Sep-Oct;7(5):370-4 [11585373.001]
  • [Cites] Thyroid. 2001 Sep;11(9):883-8 [11575859.001]
  • [Cites] Ann Acad Med Singapore. 2004 Jan;33(1):100-2 [15008573.001]
  • [Cites] Acta Pathol Microbiol Scand Suppl. 1977;(260):1-235 [269649.001]
  • [Cites] Cancer. 1989 May 1;63(9):1810-5 [2649228.001]
  • [Cites] Arch Intern Med. 1989 Jul;149(7):1575-7 [2742431.001]
  • [Cites] Am J Surg. 1989 Oct;158(4):378-80; discussion 380-1 [2802045.001]
  • [Cites] Ear Nose Throat J. 1992 Aug;71(8):350, 353-5 [1396183.001]
  • [Cites] J Laryngol Otol. 1996 Dec;110(12):1176-8 [9015439.001]
  • [Cites] Thyroid. 1994 Fall;4(3):297-300 [7833666.001]
  • [Cites] Cancer. 2002 Nov 1;95(9):1869-78 [12404280.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1994 Apr;120(4):427-30 [8166974.001]
  • [Cites] Aust N Z J Surg. 1994 Apr;64(4):286-8 [8147789.001]
  • [Cites] Am Surg. 1994 Aug;60(8):586-91 [8030813.001]
  • (PMID = 18252002.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2254624
  •  go-up   go-down


29. Ebbing J, Blind C, Stein H, Miller K, Loddenkemper C: Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy - urological viewpoint and overview of the literature to date. Rare Tumors; 2009;1(2):e54
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasizing pleomorphic adenoma presenting as an asymptomatic kidney tumor twenty-nine years after parotidectomy - urological viewpoint and overview of the literature to date.
  • Pleomorphic adenomas (benign mixed tumors) are the most common tumors of glandular origin in the head and neck and are one of the few benign neoplasms that can undergo malignant transformation.(1) Mixed tumors that are seemingly benign at the microscopic level but metastasize have been termed metastasizing mixed tumors (MZMTs).
  • We report the case of a MZMT of the kidney almost 30 years after lateral parotidectomy owing to the same tumor entity.
  • For benign mixed tumors, we are unaware of more than two other cases of metastasis to the kidney that have been published, whereas metastases to the bone, lung, and lymph nodes are more common.
  • Parotidectomy is widely accepted as the first choice of treatment,(13) but once metastases have occurred the therapeutic strategy is uncertain with surgery being the only curative option in cases with resectable disease.
  • This case report provides information about the rare event of metastatic disease to the kidney and points out therapeutic strategies.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21139933.001).
  • [ISSN] 2036-3613
  • [Journal-full-title] Rare tumors
  • [ISO-abbreviation] Rare Tumors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC2994456
  • [Keywords] NOTNLM ; carcinoma ex-mixed tumor / kidney metastasis / kidney tumor. / metastasizing mixed tumor / metastasizing pleomorphic adenoma
  •  go-up   go-down


30. Pala S, Erkol A, Kahveci G: Massive right atrial metastasis from renal cell carcinoma without inferior vena cava involvement. Turk Kardiyol Dern Ars; 2009 Jul;37(5):358
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Massive right atrial metastasis from renal cell carcinoma without inferior vena cava involvement.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Heart Neoplasms / secondary. Kidney Neoplasms / pathology

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19875913.001).
  • [ISSN] 1016-5169
  • [Journal-full-title] Türk Kardiyoloji Derneği arşivi : Türk Kardiyoloji Derneğinin yayın organıdır
  • [ISO-abbreviation] Turk Kardiyol Dern Ars
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


31. Kamiński B, Kobiorska-Nowak J, Bień S: [Distant metastases to nasal cavities and paranasal sinuses, from the organs outside the head and neck]. Otolaryngol Pol; 2008;62(4):422-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Distant metastases to nasal cavities and paranasal sinuses, from the organs outside the head and neck].
  • INTRODUCTION: The metastases from below the clavicles, to the head and neck region, are relatively uncommon, and usually demonstrate during the progression of the primary disease.
  • At that time, the correct diagnosis requires only to compare the pathology report from the primary biopsy, with the biopsy from the lump in the head and neck.
  • The majority of distant metastases to the head and neck region are localized within the lymph nodes.
  • The metastases to nasal cavity and paranasal sinuses are very rare and usually localized within the maxillary sinus.
  • MATERIAL: 4 cases, out of 46 all distant metastases to the head and neck region, localized in the nasal cavity and paranasal sinuses, diagnosed and treated in Dept. of ORL H&N surgery, Holy Cross Cancer Centre, from 2001 to 2007.
  • Case I. F. 71 years; the metastasis of colonic carcinoma to the sphenoid sinus as a first symptom of the disease).
  • The palliative Rtg-therapy was applied, and patient died in 2 months after diagnosis was established.
  • Case II. M. 69 y with metastasis of kidney cancer (Ca clarocellulare) to the nasal cavity, during a palliative stage of the disease due to multiple lung metastases.
  • The nasal cavity metastasis was treated with repeated local resections.
  • At present with no metastasis within the head and neck region--alive, in relatively good condition, with 23 months of observation.
  • Cases III. F. 50 years in palliative stage of the breast cancer, with metastases to the bones and hepar and with metastasis to the maxillary sinus.
  • Received palliative Rtg. therapy on the region of metastasis.
  • Died in 5 months after diagnosis of maxillary sinus metastasis.
  • Case IV. F. 54 years in palliative stage of the colonic cancer, with multiple metastases to the lungs and hepar; with metastasis to the maxillary sinus.
  • During hemotherapy a symptoms of tumor of the maxillary sinus appeared, confirmed as a metastasis.
  • The palliative Rtg-therapy on the region of metastasis.
  • Died in 18 months, after diagnosis of maxillary sinus metastasis.
  • CONCLUSIONS: The prognosis of metastases from distant organs, to the nasal cavity and paranasal sinuses is miserable.
  • In the majority of distant metastases to the nose and paranasal sinuses, the palliative therapy is the only possible option of treatment.
  • [MeSH-major] Adenocarcinoma / pathology. Breast Neoplasms / pathology. Carcinoma, Renal Cell / pathology. Colonic Neoplasms / pathology. Paranasal Sinus Neoplasms / secondary. Skull Base Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18837216.001).
  • [ISSN] 0030-6657
  • [Journal-full-title] Otolaryngologia polska = The Polish otolaryngology
  • [ISO-abbreviation] Otolaryngol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


32. Marshall FF: The level of cadherin-6 mRNA in peripheral blood is associated with the site of metastasis and with the subsequent occurrence of metastases in renal cell carcinoma. J Urol; 2005 Jun;173(6):1919
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The level of cadherin-6 mRNA in peripheral blood is associated with the site of metastasis and with the subsequent occurrence of metastases in renal cell carcinoma.
  • [MeSH-major] Cadherins / genetics. Carcinoma, Renal Cell / secondary. Kidney Neoplasms / diagnosis. Neoplastic Cells, Circulating. RNA, Messenger / blood
  • [MeSH-minor] Disease-Free Survival. Follow-Up Studies. Humans. Lung Neoplasms / blood. Lung Neoplasms / diagnosis. Lung Neoplasms / secondary. Neoplasm Recurrence, Local / diagnosis. Nephrectomy. Predictive Value of Tests

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15879777.001).
  • [ISSN] 0022-5347
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cadherins; 0 / K cadherin; 0 / RNA, Messenger
  •  go-up   go-down


33. Antonelli A, Zani D, Cozzoli A, Cunico SC: Surgical treatment of metastases from renal cell carcinoma. Arch Ital Urol Androl; 2005 Jun;77(2):125-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical treatment of metastases from renal cell carcinoma.
  • INTRODUCTION: Even if the number of curable renal cancers increased during the last decades, there is still a considerable amount of patients with distant metastases, evidenced at diagnosis or during the follow-up, without real curative therapeutic options.
  • MATERIALS AND METHODS: In the period between January 1983 and December 2003 we observed 252 metastatic patients among the 1187 surgically treated for renal cancer (21.2%).
  • The metastatic disease was evidenced at the diagnosis of renal tumour in 118 patients (9.9%), during the follow up at a mean distance of 18.6 months in 134 (11.3%) and was in a single organ in 200 patients, in multiple sites in 52.
  • A surgical treatment of metastases was performed in 113 cases, associated with chemo-immunotherapy in 16.
  • RESULTS: The patients with a single-site metastasis who underwent of metastases removal, especially when pulmonary or adrenal, showed a better prognosis than the ones otherwise treated, while in the patients with bony metastases, multiple-site metastases and the ones who did not receive any curative therapies an extremely dismal prognosis was evidenced.
  • However, a large amount of the patients with a single-site metastasis (79% on 159 treated patients) had a relapse of the disease, even when surgically treated (69%).
  • CONCLUSIONS: At present, in the lack of any effective systemic therapies for metastatic renal cancer, surgery offers better survival rates than other choices (chemo-immunotherapy or radiotherapy).
  • Thus, even if the initial bias in the selection of patients is surely significant, in our opinion, each patient with good performance status and a resectable metastatic lesion, better if pulmonary or adrenal, should undergo surgical treatment of metastases, that could provide long-term survival in a small part of the patients.
  • The high rate of relapses remarks the actual need of an effective systemic therapy both for the patients who can and cannot undergo surgery for their metastatic disease.

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16146280.001).
  • [ISSN] 1124-3562
  • [Journal-full-title] Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica
  • [ISO-abbreviation] Arch Ital Urol Androl
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


34. Marec-Bérard P, Crassard N, Schell M, Philip T, Thiesse P, Ranchin B, Frappaz D: Osteosarcoma metastatic to the kidney and iatrogenic hemorrhage. Pediatr Blood Cancer; 2008 Mar;50(3):690-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Osteosarcoma metastatic to the kidney and iatrogenic hemorrhage.
  • A 16-year old female presented painful masses in the lumbar region 5 years after the initial diagnosis of a localized osteosarcoma of the tibia.
  • A bone scan confirmed an increased uptake in the renal areas.
  • An ultrasound-guided fine needle biopsy confirmed the diagnosis of metastases.
  • Renal metastases from osteosarcoma are usually asymptomatic and invisible on abdominal X-rays.
  • The diagnosis is generally established by radionuclide bone scan or abdominal CT-scan.
  • [MeSH-major] Biopsy, Fine-Needle / adverse effects. Bone Neoplasms / surgery. Hemorrhage / etiology. Kidney Neoplasms / secondary. Osteosarcoma / secondary. Tibia
  • [MeSH-minor] Amputation. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Calcinosis / etiology. Calcinosis / radiography. Camptothecin / analogs & derivatives. Camptothecin / therapeutic use. Child. Combined Modality Therapy. Doxorubicin / administration & dosage. Fatal Outcome. Female. Hematuria / etiology. Humans. Iatrogenic Disease. Ilium / pathology. Lung Neoplasms / drug therapy. Lung Neoplasms / secondary. Lung Neoplasms / surgery. Methotrexate / administration & dosage. Ultrasonography, Interventional


35. Ku JH, Park HK, Lee E, Heo DS, Kim HH: Solitary squamous cell carcinoma in the kidney after metachronous development of esophageal and lung cancer. Tumori; 2005 Jan-Feb;91(1):93-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Solitary squamous cell carcinoma in the kidney after metachronous development of esophageal and lung cancer.
  • Solitary metastatic renal tumors are rarely encountered clinically.
  • We report the case of a 65-year-old man who developed a solitary renal metastasis after undergoing an esophagectomy for esophageal cancer and subsequent lobectomy for lung cancer.
  • The present case serves to demonstrate that careful follow-up is needed for esophageal cancer patients with cancer of another organ.
  • [MeSH-major] Carcinoma, Squamous Cell. Esophageal Neoplasms. Kidney Neoplasms. Lung Neoplasms. Neoplasms, Second Primary


36. Carrafiello G, Laganà D, Recaldini C, Dionigi G, Boni L, Bacuzzi A, Fugazzola C: Radiofrequency ablation of a pancreatic metastasis from renal cell carcinoma: case report. Surg Laparosc Endosc Percutan Tech; 2008 Feb;18(1):64-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiofrequency ablation of a pancreatic metastasis from renal cell carcinoma: case report.
  • CASE REPORT: This brief report describes the application of this technique for the treatment of a metastasis from renal cell carcinoma localized at the body-tail portion of the pancreas in a 77-year-old man and the outcome of the procedure at 1-year follow-up.
  • CONCLUSIONS: In our experience, RFA is feasible also for metastatic lesion at the pancreas and it was safely carried out in this case.
  • [MeSH-major] Carcinoma, Renal Cell / surgery. Catheter Ablation. Kidney Neoplasms / pathology. Pancreatic Neoplasms / surgery

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18287986.001).
  • [ISSN] 1530-4515
  • [Journal-full-title] Surgical laparoscopy, endoscopy & percutaneous techniques
  • [ISO-abbreviation] Surg Laparosc Endosc Percutan Tech
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


37. Bujons A, Pascual X, Martínez R, Rodríguez O, Palou J, Villavicencio H: Cutaneous metastases in renal cell carcinoma. Urol Int; 2008;80(1):111-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cutaneous metastases in renal cell carcinoma.
  • Cutaneous metastases from a renal cell carcinoma are rarely diagnosed during life.
  • We report a case of renal carcinoma metastatic to the skin that occurred 18 months after kidney removal.
  • The cutaneous metastasis was excised.
  • Cutaneous metastases from urological tumors are uncommon and occur in 1% of the patients, and their clinical appearance may mimic other common dermatological disorders affecting patients with advanced malignancies.
  • [MeSH-major] Carcinoma, Papillary / diagnosis. Carcinoma, Papillary / pathology. Carcinoma, Renal Cell / diagnosis. Carcinoma, Renal Cell / pathology. Kidney Neoplasms / diagnosis. Kidney Neoplasms / pathology. Skin Neoplasms / secondary. Urology / methods
  • [MeSH-minor] Biopsy. Face. Humans. Male. Middle Aged. Neoplasm Metastasis

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 S. Karger AG, Basel.
  • (PMID = 18204246.001).
  • [ISSN] 1423-0399
  • [Journal-full-title] Urologia internationalis
  • [ISO-abbreviation] Urol. Int.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


38. Nakanishi T, Kawamoto H, Fukatsu H, Ishida E, Ogawa T, Okamoto Y, Mizuno O, Tanaka S, Matsuo N, Kato J, Okada H, Shiratori Y, Omori M: [A case of resected pancreatic metastasis from renal cell carcinoma 26 years after right nephrectomy]. Nihon Shokakibyo Gakkai Zasshi; 2006 Jan;103(1):52-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of resected pancreatic metastasis from renal cell carcinoma 26 years after right nephrectomy].
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology. Pancreatic Neoplasms / secondary

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16444986.001).
  • [ISSN] 0446-6586
  • [Journal-full-title] Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
  • [ISO-abbreviation] Nihon Shokakibyo Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


39. Le Mouel S, Gaston A, Paule B: [The role of surgery in bone metastases of renal cell carcinoma: 13 case reports]. Prog Urol; 2008 Dec;18(13):1045-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The role of surgery in bone metastases of renal cell carcinoma: 13 case reports].
  • [Transliterated title] La place de la chirurgie des métastases osseuses dans le cancer du rein: à propos de 13 cas.
  • INTRODUCTION: Surgery for osseous metastases seems to improve the patients with renal cell carcinoma.
  • The goal of this study is to evaluate the efficacy and safety of surgery for osseous metastases from renal cell carcinoma.
  • MATERIALS: We performed 21 surgery for osseous metastases in 13 patients who have been treated for metastatic renal cell carcinoma at one institution between 2001 and 2007.
  • CONCLUSION: Surgery of osseous metastases is safe and effective and seems to improve outcomes of metastatic renal cell carcinoma.
  • [MeSH-major] Bone Neoplasms / secondary. Bone Neoplasms / surgery. Carcinoma, Renal Cell / secondary. Carcinoma, Renal Cell / surgery. Kidney Neoplasms / pathology


40. Stage AC, Pollock RE, Matin SF: Bilateral metastatic renal synovial sarcoma. Urology; 2005 Feb;65(2):389
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bilateral metastatic renal synovial sarcoma.
  • Synovial sarcoma is a malignant soft-tissue neoplasm, usually arising in close association with the joints and generally carrying a poor prognosis.
  • We describe the first report of bilateral renal metastases from synovial sarcoma in a long-term survivor.
  • [MeSH-major] Forearm. Kidney Neoplasms / secondary. Sarcoma, Synovial / secondary. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Amputation. Antineoplastic Agents, Alkylating / therapeutic use. Combined Modality Therapy. Female. Humans. Ifosfamide / therapeutic use. Lung Neoplasms / drug therapy. Lung Neoplasms / secondary. Lung Neoplasms / surgery. Middle Aged. Nephrectomy / methods

  • Genetic Alliance. consumer health - Synovial sarcoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. IFOSFAMIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15708068.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; UM20QQM95Y / Ifosfamide
  • [Number-of-references] 3
  •  go-up   go-down


41. Dionigi G, Uccella S, Gandolfo M, Lai A, Bertocchi V, Rovera F, Tanda ML: Solitary intrathyroidal metastasis of renal clear cell carcinoma in a toxic substernal multinodular goiter. Thyroid Res; 2008;1(1):6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Solitary intrathyroidal metastasis of renal clear cell carcinoma in a toxic substernal multinodular goiter.
  • INTRODUCTION: Thyroid gland is a rare site of clinically detectable tumor metastasis.
  • She had a history of renal clear cell carcinoma of the left kidney, which had been resected 2 years previously.
  • A histological examination revealed a solitary metastasis of a clear cell renal cancer in a diffuse multinodular goiter.
  • No distant metastases are detected.
  • CONCLUSION: Although uncommon, it is important for the endocrine surgeon and endocrine oncologist to be able to recognize and differentiate intrathyroid metastases from more primary common thyroid neoplasms.
  • The diagnosis can be suspected if the patient has a thyroid tumor and a past history of extrathyroid cancer.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Endocr J. 2008 May;55(2):359-64 [18379125.001]
  • [Cites] Thyroid. 1999 Dec;9(12):1273-80 [10646671.001]
  • [Cites] Thyroid. 2008 Jan;18(1):85-7 [17887930.001]
  • [Cites] World J Surg. 2007 May;31(5):879-87 [17308849.001]
  • [Cites] Eur J Surg Oncol. 2007 Feb;33(1):83-5 [17085008.001]
  • [Cites] Langenbecks Arch Surg. 2006 Nov;391(6):581-7 [16983577.001]
  • [Cites] Eur J Endocrinol. 2006 Jun;154(6):787-803 [16728537.001]
  • [Cites] Hum Pathol. 2005 Jun;36(6):698-701 [16021578.001]
  • [Cites] Ann Surg. 1960 Apr;151:551-61 [13820008.001]
  • [Cites] Cancer. 1956 Mar-Apr;9(2):306-9 [13304848.001]
  • [Cites] Ann Surg. 1964 Aug;160:169-77 [14209716.001]
  • [Cites] Cancer. 1962 May-Jun;15:557-65 [13911946.001]
  • [Cites] AMA Arch Pathol. 1955 Mar;59(3):291-311 [14349472.001]
  • [Cites] World J Surg. 1999 Feb;23(2):177-80; discussion 181 [9880428.001]
  • [Cites] Thyroid. 1998 Feb;8(2):149-53 [9510123.001]
  • [Cites] Am J Clin Pathol. 1998 Mar;109(3):294-301 [9495201.001]
  • [Cites] Arch Pathol Lab Med. 1998 Jan;122(1):37-41 [9448014.001]
  • [Cites] Cancer. 1997 Feb 1;79(3):574-8 [9028370.001]
  • [Cites] Ann Surg Oncol. 1995 May;2(3):252-6 [7641022.001]
  • [Cites] Endocrinol Metab Clin North Am. 1990 Sep;19(3):637-48 [2261909.001]
  • [Cites] Cancer. 1989 May 1;63(9):1810-5 [2649228.001]
  • [Cites] Tumori. 1987 Apr 30;73(2):187-90 [3554676.001]
  • [Cites] Mayo Clin Proc. 1984 Dec;59(12):856-9 [6503368.001]
  • [Cites] Pathol Res Pract. 1985 May;179(6):666-72 [4022843.001]
  • [Cites] Surg Gynecol Obstet. 1982 Oct;155(4):503-5 [7123465.001]
  • [Cites] Cancer. 1981 Sep 15;48(6):1487-91 [7272969.001]
  • [Cites] Acta Otolaryngol. 1969 May;67(5):552-62 [5378598.001]
  • [Cites] J Pathol. 1974 May;113(1):21-5 [4412457.001]
  • [Cites] Eur J Surg Oncol. 2004 Aug;30(6):583-8 [15256229.001]
  • [Cites] Thyroid. 2004 Jan;14(1):65-70 [15009916.001]
  • [Cites] Cancer. 2002 Nov 1;95(9):1869-78 [12404280.001]
  • [Cites] Clin Endocrinol (Oxf). 2002 Oct;57(4):551-6 [12354139.001]
  • [Cites] Surg Today. 2002;32(2):151-4 [11998944.001]
  • [Cites] Cancer. 2000 Mar 1;88(5):1149-58 [10699906.001]
  • [Cites] Curr Opin Otolaryngol Head Neck Surg. 2008 Apr;16(2):158-62 [18327036.001]
  • (PMID = 19014412.001).
  • [ISSN] 1756-6614
  • [Journal-full-title] Thyroid research
  • [ISO-abbreviation] Thyroid Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2596782
  •  go-up   go-down


42. Rodier JF, Tuech JJ, Wilt M, Lindas P, Bruant-Rodier C: [A locally advanced intrathyroid metastasis of bronchial cancer]. Ann Otolaryngol Chir Cervicofac; 2008 Sep;125(4):198-203
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A locally advanced intrathyroid metastasis of bronchial cancer].
  • [Transliterated title] Métastase intrathyroïdienne localement avancée d'un cancer bronchique.
  • PURPOSE: To assess the characteristics, the diagnosis and the treatment of intrathyroid metastasis.
  • METHOD: The authors report a case of a locally advanced intrathyroid metastasis of a bronchial cancer.
  • Metastatic disease was confirmed by a surgical biopsy.
  • CONCLUSION: Intrathyroid metastases are rare and usually treated by surgery.
  • Surgical management is decided taking into account the type and the kinetics of the primary tumor, the location of the thyroid metastasis, and the extension of the metastatic disease.
  • Except for isolated intrathyroid metastasis of kidney cancer, prognosis remains poor.
  • [MeSH-major] Adenocarcinoma / secondary. Adenocarcinoma / surgery. Bronchial Neoplasms / pathology. Thyroid Neoplasms / secondary. Thyroid Neoplasms / surgery. Thyroidectomy

  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18755448.001).
  • [ISSN] 0003-438X
  • [Journal-full-title] Annales d'oto-laryngologie et de chirurgie cervico faciale : bulletin de la Société d'oto-laryngologie des hôpitaux de Paris
  • [ISO-abbreviation] Ann Otolaryngol Chir Cervicofac
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


43. Medhi S, Purandare NC, Dua SG, Gujral S: Bilateral renal metastases in a case of Merkel cell carcinoma. J Cancer Res Ther; 2010 Jul-Sep;6(3):353-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bilateral renal metastases in a case of Merkel cell carcinoma.
  • It is a highly aggressive tumor which commonly metastasizes to lymph nodes, liver, lung and bone.
  • The diagnosis is based on histology and immunohistochemistry.
  • Renal metastasis, with sparing of other common sites of hematogenous spread (lung and liver), is a unique feature of this case.
  • [MeSH-major] Carcinoma, Merkel Cell / pathology. Kidney Neoplasms / diagnosis. Kidney Neoplasms / secondary. Skin Neoplasms / pathology

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21119275.001).
  • [ISSN] 1998-4138
  • [Journal-full-title] Journal of cancer research and therapeutics
  • [ISO-abbreviation] J Cancer Res Ther
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


44. Dogra P, Kumar A, Singh A: An unusual case of Von Hipple Lindau (VHL) syndrome with bilateral multicentric renal cell carcinoma with synchronous solitary urinary bladder metastasis. Int Urol Nephrol; 2007;39(1):11-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An unusual case of Von Hipple Lindau (VHL) syndrome with bilateral multicentric renal cell carcinoma with synchronous solitary urinary bladder metastasis.
  • In VHL syndrome, renal cell carcinoma is distinctive for its early age of onset, for its bilateral and multifocal involvement.
  • Synchronous solitary urinary bladder metastasis from renal cell carcinoma is extremely rare.
  • We report an unusual case of VHL with bilateral multicentric renal cell carcinoma and synchronous solitary urinary bladder metastasis.
  • [MeSH-major] Carcinoma, Renal Cell / complications. Kidney Neoplasms / complications. Neoplasms, Multiple Primary / secondary. Urinary Bladder Neoplasms / secondary. von Hippel-Lindau Disease / complications


45. Gakis G, Merseburger AS, Sotlar K, Kuczyk MA, Sievert KD, Stenzl A: Metastasis of malignant melanoma in the ureter: possible algorithms for a therapeutic approach. Int J Urol; 2009 Apr;16(4):407-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasis of malignant melanoma in the ureter: possible algorithms for a therapeutic approach.
  • We report on the very rare case of a patient with a malignant melanoma in the right ureter initially hospitalized for colic pains.
  • Histomorphological and immunohistochemical examination of the biopsy specimen demonstrated a malignant neoplasia with HMB45, Melan A and S100 positivity establishing the diagnosis of metastatic malignant melanoma.
  • Subsequently, multiple metastases in the renal pelvis and ureter led to secondary nephroureterectomy and retroperitoneal lymphadenectomy with complete excision of the ureteral orifice.
  • Secondary metastatic lesions of the urinary bladder wall were completely resected followed by dacarbazine-based chemotherapy and resection of retroperitoneal recurrences.
  • Based on this case as well as on recent published reports, we propose a possible algorithm for the treatment of metastatic melanoma of the upper urinary tract.
  • [MeSH-major] Algorithms. Melanoma / secondary. Melanoma / therapy. Skin Neoplasms / pathology. Ureteral Neoplasms / secondary. Ureteral Neoplasms / therapy

  • MedlinePlus Health Information. consumer health - Melanoma.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19416402.001).
  • [ISSN] 1442-2042
  • [Journal-full-title] International journal of urology : official journal of the Japanese Urological Association
  • [ISO-abbreviation] Int. J. Urol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


46. Miwa S, Mizokami A, Konaka H, Izumi K, Nohara T, Namiki M: A case of bone, lung, pleural and liver metastases from renal cell carcinoma which responded remarkably well to zoledronic acid monotherapy. Jpn J Clin Oncol; 2009 Nov;39(11):745-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of bone, lung, pleural and liver metastases from renal cell carcinoma which responded remarkably well to zoledronic acid monotherapy.
  • Herein, we report a rare case in which bisphosphonate zoledronic acid (ZA) effectively treated not only multiple bone metastases but also lung, pleural and liver metastases from renal cell carcinoma (RCC).
  • Recently, ZA is used to treat skeletal-related events (SREs) such as bone pain caused by bone metastasis from many kinds of cancer.
  • The patient in the present report had multiple bone metastases from RCC.
  • Remarkable improvement of the bone metastasis was observed following treatment with ZA at a dosage of 4 mg administered once every 4 weeks.
  • Moreover, lung, pleural and liver metastases also diminished markedly in size in response to the treatment.
  • The metastases have shown no progression for 20 months since starting the ZA treatment.
  • We believe that the present report is the first of its kind announcing that ZA monotherapy has been effective for lung, pleural and liver metastases from RCC.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Bone Density Conservation Agents / therapeutic use. Bone Neoplasms / drug therapy. Carcinoma, Renal Cell / secondary. Diphosphonates / therapeutic use. Imidazoles / therapeutic use. Kidney Neoplasms / pathology. Liver Neoplasms / drug therapy. Lung Neoplasms / drug therapy. Pleural Neoplasms / drug therapy


47. Kamai T, Tomosugi N, Abe H, Arai K, Yoshida K: Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma. BMC Cancer; 2009;9:270
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma.
  • We investigated whether hepcidin was involved in renal cell carcinoma (RCC).
  • METHODS: We measured serum hepcidin-25 levels in 32 patients by liquid chromatograpy (LC)-mass spectrometry (MS)/MS, and assessed hepcidin mRNA expression in paired tumor and non-tumor tissue samples from the surgical specimens of 53 consecutive patients with RCC by real-time reverse transcription polymerase chain reaction.
  • RESULTS: The serum hepcidin-25 level was higher in patients with metastatic RCC than nonmetastatic RCC (P < 0.0001), and was positively correlated with the serum interleukin-6 and C-reactive protein levels (P < 0.001).
  • Expression of hepcidin mRNA was lower in tumor tissues than in non-tumor tissues (P < 0.0001).
  • The serum hepcidin-25 level was not correlated with the expression of hepcidin mRNA in the corresponding tumor tissue specimens from 32 patients.
  • Hepcidin mRNA expression in tumor tissue was correlated with metastatic potential, but not with histological differentiation or tumor stage.
  • CONCLUSION: Our findings suggest that a high serum hepcidin-25 level may indicate the progression of RCC, and that upregulation of hepcidin mRNA expression in tumor tissue may be related to increased metastatic potential.
  • [MeSH-major] Antimicrobial Cationic Peptides / blood. Carcinoma, Renal Cell / blood. Gene Expression Regulation, Neoplastic. Kidney Neoplasms / blood
  • [MeSH-minor] Adult. Aged. C-Reactive Protein / metabolism. Female. Gene Expression Profiling. Hepcidins. Humans. Interleukin-6 / metabolism. Male. Middle Aged. Neoplasm Metastasis. RNA, Messenger / metabolism. Treatment Outcome

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oncogene. 2008 Feb 7;27(7):966-75 [17700530.001]
  • [Cites] BMC Cancer. 2007;7:159 [17697365.001]
  • [Cites] BMC Cancer. 2008;8:167 [18541040.001]
  • [Cites] J Urol. 2008 Aug;180(2):515-9 [18550105.001]
  • [Cites] Blood. 2008 Nov 15;112(10):4292-7 [18689548.001]
  • [Cites] J Urol. 2009 Mar;181(3):1004-12; discussion 1012 [19150550.001]
  • [Cites] Eur Urol. 2009 May;55(5):1145-53 [18930583.001]
  • [Cites] Biochim Biophys Acta. 2009 Dec;1796(2):75-90 [19306912.001]
  • [Cites] Clin Cancer Res. 2003 Jul;9(7):2632-41 [12855641.001]
  • [Cites] J Clin Pathol. 2000 May;53(5):388-90 [10889822.001]
  • [Cites] Cell. 2000 Oct 13;103(2):311-20 [11057903.001]
  • [Cites] J Clin Oncol. 2002 Jan 1;20(1):289-96 [11773181.001]
  • [Cites] Biochim Biophys Acta. 2002 Oct 2;1603(1):31-46 [12242109.001]
  • [Cites] J Natl Cancer Inst. 2003 Apr 2;95(7):498-9 [12671009.001]
  • [Cites] Blood. 2003 Aug 1;102(3):783-8 [12663437.001]
  • [Cites] Nat Rev Cancer. 2003 Oct;3(10):721-32 [13130303.001]
  • [Cites] J Urol. 2003 Dec;170(6 Pt 1):2163-72 [14634372.001]
  • [Cites] J Clin Invest. 2004 May;113(9):1271-6 [15124018.001]
  • [Cites] N Engl J Med. 1971 Nov 18;285(21):1182-6 [4938153.001]
  • [Cites] Cancer. 1978 Sep;42(3):1330-40 [212175.001]
  • [Cites] J Natl Cancer Inst. 1991 Nov 20;83(22):1668-72 [1749019.001]
  • [Cites] Cancer Res. 1992 Jun 15;52(12):3317-22 [1596890.001]
  • [Cites] Urol Clin North Am. 1993 May;20(2):303-21 [8493752.001]
  • [Cites] Semin Oncol. 1995 Feb;22(1):42-60 [7855619.001]
  • [Cites] N Engl J Med. 1996 Sep 19;335(12):865-75 [8778606.001]
  • [Cites] Curr Probl Cancer. 1997 Jul-Aug;21(4):185-232 [9285186.001]
  • [Cites] Br J Cancer. 1998;77(1):147-52 [9459160.001]
  • [Cites] Cell. 1998 Aug 7;94(3):281-4 [9708729.001]
  • [Cites] N Engl J Med. 1999 Feb 11;340(6):448-54 [9971870.001]
  • [Cites] Science. 2004 Dec 17;306(5704):2090-3 [15514116.001]
  • [Cites] J Endocrinol. 2005 Feb;184(2):361-70 [15684344.001]
  • [Cites] Biochem Biophys Res Commun. 2005 Dec 9;338(1):627-38 [16153592.001]
  • [Cites] Blood. 2006 Aug 15;108(4):1381-7 [16621968.001]
  • [Cites] J Clin Oncol. 2006 Dec 10;24(35):5601-8 [17158546.001]
  • [Cites] BJU Int. 2007 Jan;99(1):77-80 [16956357.001]
  • [Cites] World J Gastroenterol. 2008 Mar 7;14(9):1339-45 [18322945.001]
  • (PMID = 19656379.001).
  • [ISSN] 1471-2407
  • [Journal-full-title] BMC cancer
  • [ISO-abbreviation] BMC Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antimicrobial Cationic Peptides; 0 / HAMP protein, human; 0 / Hepcidins; 0 / Interleukin-6; 0 / RNA, Messenger; 0 / hepcidin 25, human; 9007-41-4 / C-Reactive Protein
  • [Other-IDs] NLM/ PMC2729778
  •  go-up   go-down


48. Fottner A, Szalantzy M, Wirthmann L, Stähler M, Baur-Melnyk A, Jansson V, Dürr HR: Bone metastases from renal cell carcinoma: patient survival after surgical treatment. BMC Musculoskelet Disord; 2010;11:145
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bone metastases from renal cell carcinoma: patient survival after surgical treatment.
  • BACKGROUND: Surgery is the primary treatment of skeletal metastases from renal cell carcinoma, because radiation and chemotherapy frequently are not effecting the survival.
  • METHODS: We retrospectively reviewed 101 patients operatively treated for skeletal metastases of renal cell carcinoma between 1980 and 2005.
  • RESULTS: 27 patients had a solitary bone metastasis, 20 patients multiple bone metastases and 54 patients had concomitant visceral metastases.
  • Patients with solitary bone metastases had a better survival (p < 0.001) compared to patients with multiple metastases.
  • Age younger than 65 years (p = 0.036), absence of pathologic fractures (p < 0.001) and tumor-free resection margins (p = 0.028) predicted higher survival.
  • Gender, location of metastases, time between diagnosis of renal cell carcinoma and treatment of metastatic disease, incidence of local recurrence, radiation and chemotherapy did not influence survival.
  • CONCLUSIONS: The data suggest that patients with a solitary metastasis or a limited number of resectable metastases are candidates for wide resections.
  • As radiation and chemotherapy are ineffective in most patients, surgery is a better option to achieve local tumor control and increase the survival.
  • [MeSH-major] Bone Neoplasms / mortality. Bone Neoplasms / secondary. Carcinoma, Renal Cell / mortality. Carcinoma, Renal Cell / secondary. Kidney Neoplasms / secondary
  • [MeSH-minor] Age Distribution. Age Factors. Aged. Disease Progression. Female. Fractures, Bone / epidemiology. Fractures, Bone / pathology. Fractures, Bone / physiopathology. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / physiopathology. Neoplasm Recurrence, Local / prevention & control. Neoplasm Recurrence, Local / surgery. Prognosis. Retrospective Studies. Severity of Illness Index. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Z Orthop Ihre Grenzgeb. 2006 Jan-Feb;144(1):58-67 [16498562.001]
  • [Cites] Cancer. 2005 Nov 1;104(9):1894-900 [16177996.001]
  • [Cites] Clin Orthop Relat Res. 2007 Jun;459:133-8 [17438472.001]
  • [Cites] J Bone Joint Surg Am. 2007 Aug;89(8):1794-801 [17671020.001]
  • [Cites] Clin Orthop Relat Res. 1999 Oct;(367):283-90 [10546626.001]
  • [Cites] J Bone Joint Surg Br. 2000 Jan;82(1):62-7 [10697316.001]
  • [Cites] Semin Oncol. 2000 Apr;27(2):115-23 [10768591.001]
  • [Cites] Semin Oncol. 2000 Apr;27(2):160-76 [10768595.001]
  • [Cites] J Urol. 2000 Nov;164(5):1505-8 [11025692.001]
  • [Cites] Int J Oncol. 2001 Aug;19(2):379-82 [11445855.001]
  • [Cites] J Bone Joint Surg Br. 2002 May;84(4):521-9 [12043772.001]
  • [Cites] Urology. 2003 Feb;61(2):314-9 [12597937.001]
  • [Cites] Clin Orthop Relat Res. 2003 Apr;(409):223-31 [12671506.001]
  • [Cites] J Clin Oncol. 2004 Aug 15;22(16):3316-22 [15310775.001]
  • [Cites] Clin Cancer Res. 2004 Sep 15;10(18 Pt 2):6302S-3S [15448021.001]
  • [Cites] J Urol. 1975 Jul;114(1):27-9 [1142493.001]
  • [Cites] Urology. 1978 Jun;11(6):563-7 [675922.001]
  • [Cites] Clin Orthop Relat Res. 1980 Nov-Dec;(153):106-20 [7449206.001]
  • [Cites] Urology. 1981 Dec;18(6):556-61 [7314355.001]
  • [Cites] Acta Orthop Scand. 1984 Oct;55(5):491-500 [6507069.001]
  • [Cites] J Urol. 1988 Aug;140(2):277-9 [3398121.001]
  • [Cites] Jpn J Clin Oncol. 1989 Jun;19(2):142-8 [2733167.001]
  • [Cites] J Surg Oncol. 1992 Jan;49(1):45-8 [1548881.001]
  • [Cites] J Urol. 1992 Sep;148(3):784-7 [1512825.001]
  • [Cites] Cancer. 1997 Sep 15;80(6):1103-9 [9305711.001]
  • [Cites] JAMA. 1999 May 5;281(17):1628-31 [10235157.001]
  • [Cites] Scand J Urol Nephrol. 2004;38(4):299-305 [15669589.001]
  • [Cites] Clin Orthop Relat Res. 2005 Feb;(431):187-92 [15685074.001]
  • [Cites] Eur Urol. 2007 Jul;52(1):163-8 [17098353.001]
  • (PMID = 20598157.001).
  • [ISSN] 1471-2474
  • [Journal-full-title] BMC musculoskeletal disorders
  • [ISO-abbreviation] BMC Musculoskelet Disord
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2909163
  •  go-up   go-down


49. Gołkowski F, Trofimiuk M, Czepko R, Buziak-Bereza M, Lopatka P, Adamek D, Bałdys-Waligórska A, Huszno B: Two rare cases of pituitary metastases from breast and kidney cancers. Exp Clin Endocrinol Diabetes; 2007 Sep;115(8):537-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Two rare cases of pituitary metastases from breast and kidney cancers.
  • Pituitary metastases, though very uncommon, may cause endocrine and neurosurgical problems.
  • The clinical manifestation of such metastases is highly variable.
  • Most of the metastatic pituitary tumours are oligosymptomatic.
  • We report two cases of metastatic pituitary lesions.
  • The first patient, a 52-year old female, with metastatic breast cancer, developed symptomatic anterior pituitary insufficiency.
  • The second patient, a 46-years old female presented with signs and symptoms of pituitary apoplexy and visual impairment due to metastasis from renal cancer.
  • None of them was diagnosed with diabetes insipidus, the most common manifestation related to pituitary metastatic mass.
  • [MeSH-major] Breast Neoplasms / pathology. Kidney Neoplasms / pathology. Pituitary Neoplasms / secondary
  • [MeSH-minor] Carcinoma, Ductal / pathology. Carcinoma, Ductal / surgery. Female. Humans. Middle Aged. Neoplasm Metastasis. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17853340.001).
  • [ISSN] 0947-7349
  • [Journal-full-title] Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
  • [ISO-abbreviation] Exp. Clin. Endocrinol. Diabetes
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


50. Morais C, Pat B, Gobe G, Johnson DW, Healy H: Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines. Nephrol Dial Transplant; 2006 Dec;21(12):3377-88
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pyrrolidine dithiocarbamate exerts anti-proliferative and pro-apoptotic effects in renal cell carcinoma cell lines.
  • BACKGROUND: The activation of nuclear factor-kappaB (NF-kappaB) has been implicated in the development, progression and metastasis of renal cell carcinoma (RCC).
  • This study investigates the effect of pyrrolidine dithiocarbamate (PDTC), a NF-kappaB inhibitor, on two metastatic human RCC cell lines, ACHN and SN12K1.
  • [MeSH-major] Apoptosis / drug effects. Carcinoma, Renal Cell / drug therapy. Carcinoma, Renal Cell / pathology. Cell Proliferation / drug effects. Kidney Neoplasms / drug therapy. Kidney Neoplasms / pathology. NF-kappa B / antagonists & inhibitors. Pyrrolidines / therapeutic use. Thiocarbamates / therapeutic use
  • [MeSH-minor] Cell Line, Tumor. Humans

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16998220.001).
  • [ISSN] 0931-0509
  • [Journal-full-title] Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • [ISO-abbreviation] Nephrol. Dial. Transplant.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / NF-kappa B; 0 / Pyrrolidines; 0 / Thiocarbamates; 25769-03-3 / pyrrolidine dithiocarbamic acid
  •  go-up   go-down


51. David AW, Samuel R, Eapen A, Vyas F, Joseph P, Sitaram V: Pancreatic metastasis from renal cell carcinoma 16 years after nephrectomy: a case report and review of the literature. Trop Gastroenterol; 2006 Oct-Dec;27(4):175-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pancreatic metastasis from renal cell carcinoma 16 years after nephrectomy: a case report and review of the literature.
  • Two percent of all malignant pancreatic tumors are metastases from other primaries, with small cell lung cancer, colorectal cancer, breast cancer and hematological neoplasms being the commonest.
  • Renal cell carcinoma (RCC) metastasizing to the pancreas is rare and occurs in 2.8% of patients with metastatic RCC.
  • However, RCC is the most common primary leading to solitary pancreatic metastasis.
  • Metastases often present many years after nephrectomy for primary RCC (median time of 8 years) and should therefore be looked for on surveillance or when patients present with upper abdominal symptoms.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology. Pancreatic Neoplasms / secondary

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17542297.001).
  • [ISSN] 0250-636X
  • [Journal-full-title] Tropical gastroenterology : official journal of the Digestive Diseases Foundation
  • [ISO-abbreviation] Trop Gastroenterol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] India
  • [Number-of-references] 7
  •  go-up   go-down


52. Anglada-Curado FJ, De Haro-Padilla J, Carrasco-Valiente J, Alvarez-Kindelan J, Ruiz-Garcia J, Requena-Tapia MJ: Hand metastasis from renal carcinoma. Urology; 2010 Oct;76(4):846
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hand metastasis from renal carcinoma.
  • Renal carcinoma may develop metachronous distant metastases without evidence of regional or local disease recurrence.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Hand / pathology. Kidney Neoplasms / pathology. Skin Neoplasms / secondary
  • [MeSH-minor] Aged. Brain Neoplasms / secondary. Female. Hand Injuries / complications. Humans. Nephrectomy

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20138337.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


53. Muacevic A, Siebels M, Tonn JC, Wowra B: Treatment of brain metastases in renal cell carcinoma: radiotherapy, radiosurgery, or surgery? World J Urol; 2005 Jul;23(3):180-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Treatment of brain metastases in renal cell carcinoma: radiotherapy, radiosurgery, or surgery?
  • Metastases from renal cell carcinoma raise specific therapeutic problems because they are relatively unresponsive to whole brain radiation therapy and tend to bleed.
  • Recently, stereotactically guided high-precision irradiation as a single dose application (radiosurgery) showed promising treatment results for selected patients with brain metastases from renal cell carcinoma.
  • [MeSH-major] Brain Neoplasms / radiotherapy. Brain Neoplasms / surgery. Carcinoma, Renal Cell / radiotherapy. Carcinoma, Renal Cell / surgery. Kidney Neoplasms / pathology

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiologe. 1997 Dec;37(12):995-1002 [9498251.001]
  • [Cites] Expert Rev Anticancer Ther. 2002 Oct;2(5):495-506 [12382518.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):753-9 [9128947.001]
  • [Cites] Minim Invasive Neurosurg. 2004 Aug;47(4):203-8 [15346315.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2076-80 [8134351.001]
  • [Cites] Cancer. 1998 Jul 15;83(2):344-53 [9669818.001]
  • [Cites] J Clin Neurosci. 2000 Sep;7(5):414-8 [10942662.001]
  • [Cites] J Neurosurg. 1996 May;84(5):748-54 [8622147.001]
  • [Cites] Cleve Clin J Med. 2000 Feb;67(2):120-7 [10680278.001]
  • [Cites] J Neurol. 2002 Oct;249(10):1357-69 [12382150.001]
  • [Cites] Cancer. 1988 Nov 1;62(9):1912-7 [2458823.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Mar 15;46(5):1155-61 [10725626.001]
  • [Cites] Lancet. 2004 May 22;363(9422):1665-72 [15158627.001]
  • [Cites] Neurology. 2000 May 23;54(10):1886-93 [10822423.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):291-8 [10802351.001]
  • [Cites] Ann Neurol. 1980 Jun;7(6):529-41 [7436358.001]
  • [Cites] J Neurooncol. 2003 Jan;61(1):35-44 [12587794.001]
  • [Cites] J Neurosurg. 2002 Oct;97(4):785-93 [12405364.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1980 Jan;6(1):11-5 [6154025.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1996 Apr 1;35(1):27-35 [8641923.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2001 Oct 1;51(2):426-34 [11567817.001]
  • [Cites] Neurosurgery. 2002 Sep;51(3):656-65; discussion 665-7 [12188943.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1980 Jan;6(1):1-9 [6154024.001]
  • [Cites] J Neurosurg. 2003 Feb;98(2):342-9 [12593621.001]
  • [Cites] J Neurosurg. 2000 May;92(5):760-5 [10794288.001]
  • [Cites] Rev Neurol (Paris). 1992;148(6-7):477-87 [1448668.001]
  • [Cites] Cancer. 1998 Dec 15;83(12):2548-53 [9874462.001]
  • [Cites] J Natl Cancer Inst. 1995 Jan 4;87(1):34-40 [7666461.001]
  • [Cites] Urology. 1996 Feb;47(2):187-93 [8607231.001]
  • [Cites] Acta Neurochir (Wien). 1998;140(6):549-55 [9755321.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Jul 1;47(4):1007-12 [10863072.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1981 Jul;7(7):891-5 [6171553.001]
  • [Cites] J Neurosurg. 2002 Dec;97(5 Suppl):489-93 [12507083.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1990 Jul;19(1):111-5 [2116386.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1994 Mar 1;28(4):797-802 [8138431.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1987 Feb;13(2):279-82 [3102416.001]
  • [Cites] J Neurosurg. 1999 Jul;91(1):35-43 [10389878.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1997 Mar 1;37(4):745-51 [9128946.001]
  • [Cites] Am Fam Physician. 1994 Mar;49(4):787-97 [8116514.001]
  • [Cites] J Clin Oncol. 1988 Oct;6(10):1621-4 [3171627.001]
  • [Cites] JAMA. 1998 Nov 4;280(17):1485-9 [9809728.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1992;23(2):413-8 [1375218.001]
  • [Cites] Cancer. 1992 Feb 15;69(4):972-80 [1735089.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1989 Mar;16(3):669-73 [2646260.001]
  • [Cites] Cancer Treat Rev. 2003 Dec;29(6):533-40 [14585263.001]
  • [Cites] Am J Clin Oncol. 1997 Jun;20(3):303-7 [9167759.001]
  • [Cites] BJU Int. 2000 Oct;86(6):613-8 [11069364.001]
  • [Cites] N Engl J Med. 1990 Feb 22;322(8):494-500 [2405271.001]
  • (PMID = 15791468.001).
  • [ISSN] 0724-4983
  • [Journal-full-title] World journal of urology
  • [ISO-abbreviation] World J Urol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 48
  •  go-up   go-down


54. Zhou HK, Zhao YB, Zheng SB, Chen T, Mao XM, Qi H, Wu RJ: [Association of S100A4 mRNA expression with differentiation and metastasis of renal cell carcinoma]. Di Yi Jun Yi Da Xue Xue Bao; 2005 Jun;25(6):712-4, 717
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Association of S100A4 mRNA expression with differentiation and metastasis of renal cell carcinoma].
  • OBJECTIVE: To study the association of S100A4 mRNA expression level with the differentiation and metastasis of renal cell carcinoma (RCC).
  • METHODS: Tissue specimens were obtained from 31 patients undergoing surgery for renal cell carcinomas between May 2001 and May 2004.
  • Reverse transcriptional PCR was performed for amplification of S100A4 mRNA (212 bp) from 31 RCC tissues and matched normal kidney tissues besides the tumor, and the differential S100A4 mRNA expression was analyzed for its association with the clinical manifestations of the patients.
  • Patients with poorly differentiated RCC had significantly higher S100A4 expression index than those with well differentiated RCC (7.94 vs 5.06, P<0.001), and patients with metastasis also had higher expression index (9.61 vs 5.53, P<0.001).
  • No obvious difference was noted in the expression index between granular cell tumor and clear cell carcinoma (6.98 vs 6.02, P>0.05).
  • Differential expression of S100A4 mRNA is correlated to the metastasis of RCC.
  • [MeSH-major] Carcinoma, Renal Cell / genetics. Cell Transformation, Neoplastic / genetics. Gene Expression Profiling. Kidney Neoplasms / genetics. S100 Proteins / biosynthesis
  • [MeSH-minor] Biomarkers, Tumor. Cells. Humans. Neoplasm Metastasis. RNA, Messenger / biosynthesis. RNA, Messenger / genetics. Tumor Cells, Cultured

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15958317.001).
  • [ISSN] 1000-2588
  • [Journal-full-title] Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA
  • [ISO-abbreviation] Di Yi Jun Yi Da Xue Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / RNA, Messenger; 0 / S100 Proteins; 142662-27-9 / S100A4 protein, human
  •  go-up   go-down


56. Narea-Matamala G, Fernández-Toro Mde L, Villalabeitía-Ugarte E, Landaeta-Mendoza M, Rojas-Alcayaga G: Oral metastasis of renal cell carcinoma, presentation of a case. Med Oral Patol Oral Cir Bucal; 2008 Nov;13(11):E742-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oral metastasis of renal cell carcinoma, presentation of a case.
  • The oral cavity constitutes a site of low prevalence for metastasis of malignant tumors.
  • Nevertheless, it has a high prevalence for metastasis of renal origin.
  • Besides the kidneys, there are other primary sites with high prevalence of metastasis to the oral mucosa, such as the lungs, skin and breasts.
  • Metastasis is common in patients with a background of treated renal tumors, thereby, it is proper to determine the possibility of oral metastasis as part of the protocol of attention.
  • However, it constitutes a diagnostic challenge when it presents in patients with no renal antecedents.
  • It is in this type of patients that the diagnosis of carcinoma is achieved by means of a metastasis.
  • Survival rate in these patients is short because at the time of the metastasis diagnosis, the general compromise is high.
  • The following report describes a case referred from the Rheumatology Unit with an intraoral tumor, that was finally diagnosed as a Metastasic Renal Cell Carcinoma with multiple metastasis.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology. Mouth Neoplasms / secondary

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18978718.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


57. Saldarriaga J, Schwartz J, De Perot T, Vallée JP, Iselin C: [Renal mass biopsy: usefulness and indications]. Rev Med Suisse; 2010 Dec 8;6(274):2358-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Renal mass biopsy: usefulness and indications].
  • Whereas renal biopsy is routinely performed in nephrology for the management of renal failure or follow-up of kidney grafts, it has historically been seldom used in urology for the work-up of kidney tumours because of its low yield.
  • Since a few years however, some authors recommend to biopsy select renal lesions to improve their diagnosis and management.
  • Renal biopsy appears now to be useful for managing atypical solid renal lesions, those < or =3 cm, possible neoplastic lesions in solitary kidneys, bilateral renal tumours, putative renal metastasis, so as lesions in functionally deficient kidneys.
  • [MeSH-major] Kidney / pathology. Kidney Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21290868.001).
  • [ISSN] 1660-9379
  • [Journal-full-title] Revue médicale suisse
  • [ISO-abbreviation] Rev Med Suisse
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


58. Kumar A, Dogra PN, Sharma MC: Isolated metachronous cutaneous metastases from renal cell carcinoma. Indian J Cancer; 2010 Oct-Dec;47(4):482-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Isolated metachronous cutaneous metastases from renal cell carcinoma.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology. Skin Neoplasms / secondary


59. Stránský P, Hora M, Eret V, Klecka J, Urge T, Grégrová H, Dvoráková E, Hes O, Chudácek Z, Kreuzberg B: [Laparoscopic adrenalectomy]. Rozhl Chir; 2009 Sep;88(9):514-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Mean tumour size was 4.1 +/- 2 cm (range 1-10.1 cm), mean operation time was 89 +/- 38 minutes (range 32-220 minutes), mean blood loss was 33 +/- 75 ml (range 0-400 ml), mean hospitalization time was 6.1 days (range 3-12 days).
  • There were histologically 15 cortical adenomas, 5 nodular cortical hyperplasia, 1 calcificated hematoma, 3 cysts, 2 potentional malignant tumours on interface between adenoma and carcinoma, 1 cortical carcinoma and 7 pheochromocytoma.
  • We found 3 metastases of renal carcinoma in adrenal gland and one metastasis mesenchymal chondrosarcoma too.
  • Especially benign tumours of smaller size (by 8 cm) are indicated, extensive and especially malignant tumours remain a domain of open approach.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20052929.001).
  • [ISSN] 0035-9351
  • [Journal-full-title] Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti
  • [ISO-abbreviation] Rozhl Chir
  • [Language] cze
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Czech Republic
  •  go-up   go-down


60. Kunkle DA, Crispen PL, Li T, Uzzo RG: Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses. J Urol; 2007 May;177(5):1692-6; discussion 1697
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses.
  • PURPOSE: Active surveillance of small incidental renal masses is associated with slow radiographic growth and a low risk of metastatic progression.
  • Radiographic tumor size, in the absence of histological data, is the only prognostic indicator available when considering active surveillance.
  • To better define the relationship between tumor size and the metastatic potential of small renal masses, we investigated whether radiographic tumor size predicts for the presence of synchronous metastases in renal cell carcinoma.
  • MATERIALS AND METHODS: We reviewed our institutional tumor registry to identify sporadic pathologically verified renal cell carcinoma treated during an 8-year period.
  • We analyzed data regarding primary tumor size and the presence of biopsy proven synchronous metastatic disease at presentation.
  • RESULTS: We compared 110 cases of renal cell carcinoma with biopsy proven synchronous metastatic disease at presentation to 250 controls with clinically localized renal cell carcinoma.
  • Tumors associated with synchronous metastasis were significantly larger than localized lesions (median 8.0 cm [range 2.2 to 20.0] vs 4.5 cm [range 0.3 to 17.5], p <0.0001).
  • The probability of synchronous metastasis increased with increasing primary tumor size (p <0.0001).
  • There were no patients with tumors 2 cm or smaller who presented with biopsy confirmed metastatic disease and less than 5% (5 of 110) of all synchronous metastasis occurred in tumors 3.0 cm or smaller.
  • Logistic regression models determined that the odds of synchronous metastasis increased by 22% for each 1 cm increase in tumor size.
  • CONCLUSIONS: Radiographic tumor size is a significant clinical predictor of the presence of biopsy proven synchronous metastatic renal cell carcinoma.
  • In our series the odds of presenting with synchronous, biopsy proven metastatic disease increased by 22% with each 1 cm increase in tumor size.
  • A 100% odds increase, or doubling of the risk of metastasis, occurs with a 3.5 cm increase in primary tumor size.
  • These data have important implications for extent of disease evaluations in patients with large tumors and for the active surveillance of small enhancing renal masses.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology. Neoplasms, Multiple Primary / secondary
  • [MeSH-minor] Disease Progression. Humans. Neoplasm Staging. Odds Ratio. Prognosis. Prospective Studies

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17437785.001).
  • [ISSN] 0022-5347
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


61. Tanaka T, Jiang S, Hotta H, Takano K, Iwanari H, Sumi K, Daigo K, Ohashi R, Sugai M, Ikegame C, Umezu H, Hirayama Y, Midorikawa Y, Hippo Y, Watanabe A, Uchiyama Y, Hasegawa G, Reid P, Aburatani H, Hamakubo T, Sakai J, Naito M, Kodama T: Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer. J Pathol; 2006 Apr;208(5):662-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer.
  • Using immunohistochemical analysis, we demonstrate that, while P1 promoter-driven HNF4alpha is expressed in hepatocytes, small intestine, colon, kidney and epididymis, P2 promoter-driven HNF4alpha is expressed in bile duct, pancreas, stomach, small intestine, colon and epididymis.
  • HNF4alpha was expressed in lung metastases from renal cell, hepatocellular and colorectal carcinoma but was not observed in lung tumours.
  • The P1 and P2 promoter-driven HNF4alpha expression pattern of tumour metastases correlated with the primary site of origin.
  • These data provide evidence for the tissue distribution of P1 and P2 promoter-driven HNF4alpha at the protein level and suggest that HNF4alpha may be a novel diagnostic marker for metastases of unknown primary.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Cell Transformation, Neoplastic / genetics. Hepatocyte Nuclear Factor 4 / metabolism. Neoplasms / metabolism. Promoter Regions, Genetic
  • [MeSH-minor] Animals. Antibodies, Monoclonal / immunology. Antibody Specificity. Female. Gene Expression Regulation, Neoplastic. Humans. Lung Neoplasms / metabolism. Lung Neoplasms / secondary. Male. Neoplasm Proteins / genetics. Neoplasm Proteins / immunology. Neoplasm Proteins / metabolism. Precancerous Conditions / metabolism. RNA, Messenger / genetics. RNA, Neoplasm / genetics. Reverse Transcriptase Polymerase Chain Reaction / methods. Stomach Neoplasms / metabolism. Tissue Distribution. Tumor Cells, Cultured

  • Guide to Pharmacology. gene/protein/disease-specific - Hepatocyte nuclear factor-4-alpha / NR2A1 - data and references .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16400631.001).
  • [ISSN] 0022-3417
  • [Journal-full-title] The Journal of pathology
  • [ISO-abbreviation] J. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Biomarkers, Tumor; 0 / Hepatocyte Nuclear Factor 4; 0 / Neoplasm Proteins; 0 / RNA, Messenger; 0 / RNA, Neoplasm
  •  go-up   go-down


62. Nagai T, Igase M, Ochi M, Nagai A, Takada K, Kohara K, Miki T: [Multiple metastases from renal carcinoma 15 years after nephrectomy]. Nihon Ronen Igakkai Zasshi; 2007 Nov;44(6):747-51
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Multiple metastases from renal carcinoma 15 years after nephrectomy].
  • He underwent left total nephrectomy for renal cell carcinoma (RCC) 15 years previously (in 1990).
  • Since further evaluation yielded no evidence of extra renal metastases, he was followed up in the outpatient clinic.
  • On admission, there was a hard tumor in the right axilla.
  • Ultrasonography demonstrated a vascular tumor with a smooth surface, 26 by 24mm.
  • Laboratory findings were generally close to normal, including tumor markers.
  • Chest contrast-enhanced dynamic CT showed that the tumor was enhanced.
  • Open simple axillary mass biopsy was performed on August 2 and the tumor was histologically confirmed as a metastasis of the RCC to the axillary.
  • His overall status was normal, and he underwent an operation for the pancreas tumor and the tumor in the rectus muscle of the abdomen.
  • On histological examination, both excised specimens were found to be metastases of RCC.
  • During 2 years follow-up period in the outpatient clinic, additional metastasis has not been observed in any organ.
  • Since this case confirms the potential of RCC for late and multiple distant metastases, careful long-term follow-up after radical nephrectomy is needed.
  • [MeSH-major] Carcinoma, Renal Cell / pathology. Kidney Neoplasms / pathology. Muscle Neoplasms / secondary. Nephrectomy. Pancreatic Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18198458.001).
  • [ISSN] 0300-9173
  • [Journal-full-title] Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics
  • [ISO-abbreviation] Nihon Ronen Igakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


63. Jafri M, Protheroe A: An update on a case of regression of lung metastases after radiotherapy for bone metastasis in renal cell carcinoma. Clin Oncol (R Coll Radiol); 2008 May;20(4):316
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An update on a case of regression of lung metastases after radiotherapy for bone metastasis in renal cell carcinoma.
  • [MeSH-major] Bone Neoplasms / radiotherapy. Bone Neoplasms / secondary. Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology. Lung Neoplasms / secondary


64. Sadler GJ, Anderson MR, Moss MS, Wilson PG: Metastases from renal cell carcinoma presenting as gastrointestinal bleeding: two case reports and a review of the literature. BMC Gastroenterol; 2007;7:4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastases from renal cell carcinoma presenting as gastrointestinal bleeding: two case reports and a review of the literature.
  • Renal cell carcinoma constitutes 3% of all adult malignancies and often presents insidiously.
  • Consequently 25-30% of patients have metastases at the time of diagnosis.
  • Gastrointestinal bleeding from renal cell carcinoma metastases is an uncommon and under-recognised manifestation of this disease.
  • CASE REPORT: In this report we describe two cases of gastrointestinal bleeding from renal cell carcinoma metastases - in one patient bleeding heralded the primary manifestation of disease and in the other signified recurrence of disease following nephrectomy.
  • CONCLUSION: These cases highlight the importance endoscopic vigilance in cases of undiagnosed upper gastrointestinal haemorrhage, especially in patients with a past history of renal cell carcinoma.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Duodenal Neoplasms / secondary. Gastrointestinal Hemorrhage / etiology. Kidney Neoplasms / diagnosis. Pancreatic Neoplasms / secondary


65. Sakamoto N, Monzawa S, Miyake M, Watanabe H, Hamanaka A, Motohara T, Adachi S, Kanbara Y, Kawaguchi K, Etoh H, Hanioka K: Portal venous tumor thrombus associated with hepatic metastasis of renal cell carcinoma: case report. Abdom Imaging; 2006 Mar-Apr;31(2):245-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Portal venous tumor thrombus associated with hepatic metastasis of renal cell carcinoma: case report.
  • We report a case of liver metastasis of renal cell carcinoma with portal venous tumor thrombus.
  • The histologic specimen confirmed metastatic liver tumor of renal cell carcinoma with portal venous tumor thrombus.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology. Liver Neoplasms / secondary. Neoplasm Recurrence, Local / diagnosis. Portal Vein / radiography. Thrombosis / diagnosis


66. Cozar JM, Aptsiauri N, Tallada M, Garrido F, Ruiz-Cabello F: Late pulmonary metastases of renal cell carcinoma immediately after post-transplantation immunosuppressive treatment: a case report. J Med Case Rep; 2008;2:111
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Late pulmonary metastases of renal cell carcinoma immediately after post-transplantation immunosuppressive treatment: a case report.
  • INTRODUCTION: We report a case of pulmonary metastatic recurrence of renal adenocarcinoma soon after radical nephrectomy that was followed by renal transplant and immunosuppressive medication.
  • Increased risk of metastatic recurrence of renal cell carcinoma should be considered in the immediate post-transplant period when immunosuppressive medication is administered, even if nephrectomy had been performed many years earlier.
  • CASE PRESENTATION: In 1986 the patient demonstrated renal insufficiency secondary to mesangial glomerulonephritis.
  • In 1992 he underwent left side radical nephrectomy with histopathological diagnosis of clear cell adenocarcinoma.
  • Mesangial glomerulonephritis in the remaining right kidney progressed to end-stage renal failure.
  • In October 2000 he received a kidney transplant from a cadaver and commenced immunosuppressive medication.
  • Two months later, several nodules were found in his lungs, which were identified as metastases from the primary renal tumor that had been removed with the diseased kidney 8 years earlier.
  • CONCLUSION: Recurrence of renal cell carcinoma metastases points to tumor dormancy and reflects a misbalance between effective tumor immune surveillance and immune escape.
  • This case demonstrates that a state of tumor dormancy can be interrupted soon after administration of immunosuppressant medication.

  • Andalusian Health Repository. Full Text from .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BJU Int. 1999 Sep;84(4):405-11 [10468753.001]
  • [Cites] J Urol. 1998 Apr;159(4):1163-7 [9507823.001]
  • [Cites] Nat Immunol. 2002 Nov;3(11):999-1005 [12407407.001]
  • [Cites] Surg Today. 2003;33(5):395-8 [12734740.001]
  • [Cites] Jpn J Clin Oncol. 2004 Jan;34(1):46-9 [15020663.001]
  • [Cites] J Urol. 2004 Jul;172(1):58-62 [15201737.001]
  • [Cites] JAMA. 2004 Jul 7;292(1):97-100 [15238597.001]
  • [Cites] Cancer. 2005 Jan 15;103(2):251-7 [15593084.001]
  • [Cites] Curr Urol Rep. 2005 Feb;6(1):7-18 [15610692.001]
  • [Cites] Am J Transplant. 2005 Dec;5(12):3015-8 [16303018.001]
  • [Cites] Int J Urol. 2006 Apr;13(4):431-2 [16734864.001]
  • [Cites] Rev Urol. 2006 Winter;8(1):1-7 [16985554.001]
  • [Cites] Int J Urol. 2006 Dec;13(12):1525-7 [17118029.001]
  • [Cites] Int Rev Cytol. 2007;256:139-89 [17241907.001]
  • [Cites] Curr Opin Immunol. 2007 Apr;19(2):203-8 [17292599.001]
  • [Cites] Nat Rev Cancer. 2007 Nov;7(11):834-46 [17957189.001]
  • [Cites] J Urol. 1981 Jul;126(1):17-23 [7253072.001]
  • [Cites] J Theor Biol. 1994 Aug 21;169(4):327-38 [7967626.001]
  • [Cites] Nat Med. 1997 May;3(5):505-9 [9142117.001]
  • [Cites] Adv Ren Replace Ther. 2000 Apr;7(2):147-56 [10782732.001]
  • (PMID = 18423038.001).
  • [ISSN] 1752-1947
  • [Journal-full-title] Journal of medical case reports
  • [ISO-abbreviation] J Med Case Rep
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2359763
  •  go-up   go-down


67. Pollock BE: Commentary (Pollock): Radiation Therapy in the Management of Brain Metastases From Renal Cell Carcinoma. Oncology (Williston Park); 2006 May 01;20(6)
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Commentary (Pollock): Radiation Therapy in the Management of Brain Metastases From Renal Cell Carcinoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28326510.001).
  • [ISSN] 0890-9091
  • [Journal-full-title] Oncology (Williston Park, N.Y.)
  • [ISO-abbreviation] Oncology (Williston Park, N.Y.)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


68. Shuch B, Said J, LaRochelle JC, Zhou Y, Li G, Klatte T, Pouliot F, Kabbinavar FF, Belldegrun AS, Pantuck AJ: Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy. Cancer; 2010 Feb 1;116(3):616-24
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy.
  • BACKGROUND: Sarcomatoid features in renal cell carcinoma may represent an aggressive subclone arising from the primary tumor.
  • The patterns of metastases for these tumors were evaluated to determine if sarcomatoid features were retained at metastasis and whether the percentage of sarcomatoid features in the primary tumor influenced spread.
  • METHODS: All patients with sarcomatoid features found at nephrectomy with synchronous or metachronous resection of metastases were evaluated.
  • The histology, grade, and percentage of sarcomatoid features in the primary and metastatic site were recorded.
  • The association between percentage of sarcomatoid features, grade, histology, and pattern of metastases was evaluated.
  • RESULTS: Thirty-two patients were identified with sarcomatoid features and resected metastases.
  • Fifty-two metastatic sites were evaluated.
  • Histology and carcinoma grade did not influence metastatic pattern; however, greater percentage of sarcomatoid features was associated with the presence of distant sarcomatoid histology.
  • A cutoff of 30% sarcomatoid features in the primary tumor was useful in predicting systemic sarcomatoid histology.
  • CONCLUSIONS: Sarcomatoid elements are frequently observed in the metastases of primary tumors with sarcomatoid features, and these metastases generally contain a solitary pattern supporting the subclone hypothesis.
  • The percentage of sarcomatoid features influences the pattern of spread, and patients with >30% sarcomatoid features in the primary tumor frequently have distant sarcomatoid histology.

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 American Cancer Society.
  • [Cites] Am J Surg Pathol. 2001 Mar;25(3):275-84 [11224597.001]
  • [Cites] J Surg Oncol. 2001 Jun;77(2):123-31 [11398166.001]
  • [Cites] Cancer Genet Cytogenet. 2002 Apr 1;134(1):38-40 [11996794.001]
  • [Cites] J Urol. 2002 Sep;168(3):959-61 [12187199.001]
  • [Cites] Cancer. 2003 Dec 15;98(12):2566-75 [14669275.001]
  • [Cites] Am J Surg Pathol. 2004 Apr;28(4):435-41 [15087662.001]
  • [Cites] Cancer. 2004 Oct 1;101(7):1545-51 [15378501.001]
  • [Cites] J Urol. 1983 Oct;130(4):657-9 [6887392.001]
  • [Cites] Cancer. 1985 Nov 15;56(10):2452-7 [3899348.001]
  • [Cites] Cancer. 1987 Feb 1;59(3):516-26 [3791160.001]
  • [Cites] J Urol. 1987 Jan;137(1):25-8 [3025462.001]
  • [Cites] Cancer. 1993 Apr 1;71(7):2292-8 [8095849.001]
  • [Cites] Arch Pathol Lab Med. 1993 Jun;117(6):636-40 [7684893.001]
  • [Cites] Cancer. 1997 Sep 1;80(5):987-9 [9307203.001]
  • [Cites] Am J Surg Pathol. 1997 Oct;21(10):1188-95 [9331291.001]
  • [Cites] J Pathol. 1997 Oct;183(2):131-3 [9390023.001]
  • [Cites] J Pathol. 1998 Aug;185(4):382-8 [9828836.001]
  • [Cites] J Clin Oncol. 1999 Feb;17(2):523-8 [10080595.001]
  • [Cites] Pathology. 1999 Aug;31(3):185-90 [10503259.001]
  • [Cites] Cancer. 2005 Sep 15;104(6):1195-203 [16047350.001]
  • [Cites] J Surg Oncol. 2007 Mar 15;95(4):317-23 [17066434.001]
  • [Cites] J Urol. 2007 Apr;177(4):1258-63 [17382701.001]
  • [Cites] J Clin Oncol. 2009 Jan 10;27(2):235-41 [19064974.001]
  • [CommentIn] Cancer. 2010 Feb 1;116(3):574-6 [19957322.001]
  • (PMID = 19998348.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / P30 CA016042-35; United States / NCCIH NIH HHS / AT / AT003960-01A1; United States / NCI NIH HHS / CA / P30 CA016042; United States / NCCIH NIH HHS / AT / P01 AT003960; United States / NCCIH NIH HHS / AT / P01 AT003960-01A1; United States / NCI NIH HHS / CA / CA016042-35
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS316703; NLM/ PMC3162346
  •  go-up   go-down


69. Dogrul AB, Erol T, Karakoc D, Hamaloglu E, Ozdemir A, Ozenc A: Renal cell carcinoma metastasis to focal nodular hyperplasia focus on liver in a patient with Von Hippel-Lindau disease. Am J Med Sci; 2009 Aug;338(2):159-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Renal cell carcinoma metastasis to focal nodular hyperplasia focus on liver in a patient with Von Hippel-Lindau disease.
  • Von Hippel-Lindau disease is an autosomal dominant disorder occurring in 1 of 36,000 births and associated with various tumors and cysts in the central nervous system and other visceral organs.
  • At present, metastasis from renal cell carcinoma (RCC) and neurologic complications are the most common causes of death from Von Hippel-Lindau disease.
  • We report a case of Von Hippel-Lindau disease diagnosed during a screening and was found to have metastasis of RCC to a focal nodular hyperplasia lesion on the liver.
  • In the literature, misdiagnosis of benign liver lesions as metastases of RCC has been reported, but there has not been a case reported to have a metastasis of RCC within a benign liver lesion.
  • To our knowledge, this is the first case of RCC metastasis to a benign lesion of the liver.
  • [MeSH-major] Carcinoma, Renal Cell / pathology. Kidney Neoplasms / pathology. Liver / pathology. Liver Neoplasms / secondary. von Hippel-Lindau Disease / complications


70. Machado NO, Chopra P: Pancreatic metastasis from renal carcinoma managed by Whipple resection. A case report and literature review of metastatic pattern, surgical management and outcome. JOP; 2009;10(4):413-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pancreatic metastasis from renal carcinoma managed by Whipple resection. A case report and literature review of metastatic pattern, surgical management and outcome.
  • CONTEXT: Metastatic cancer to the pancreas is rare and accounts for less than 2% of all pancreatic malignancies, metastasis from renal cell carcinoma being predominant.
  • While symptomatic patients present with obstructive jaundice, abdominal pain, or GI bleeding, the diagnosis is often made in asymptomatic patients during follow-up for renal cell carcinoma.
  • Hence, a high index of clinical suspicion is required in a patient who presents with a pancreatic tumor following a nephrectomy for renal cell carcinoma.
  • CASE REPORT: We report the case of a patient in whom a lesion was detected in the head of the pancreas, following a nephrectomy performed 5 years previously for renal cell carcinoma.
  • The patient underwent a pancreaticoduodenectomy and histopathology confirmed a metastatic renal cell carcinoma.
  • The literature is reviewed for pancreatic metastasis from renal cell carcinoma, for metastatic pattern, surgical management and outcome.
  • CONCLUSION: Pancreatic metastases are usually detected during the follow-up of patients having undergone a previous nephrectomy for renal cell carcinoma.
  • Typically, the interval between a nephrectomy and pancreatic metastasis is long.
  • The literature contained more than 250 cases of pancreatic resection for metastatic renal cell carcinoma.
  • A high resectability rate is characteristic of metastasis from renal cell carcinoma as compared to primary pancreatic cancer.
  • [MeSH-major] Carcinoma, Renal Cell / pathology. Kidney Neoplasms / pathology. Pancreatic Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19581746.001).
  • [ISSN] 1590-8577
  • [Journal-full-title] JOP : Journal of the pancreas
  • [ISO-abbreviation] JOP
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Italy
  • [Number-of-references] 33
  •  go-up   go-down


71. Opper B, Elsner P, Ziemer M: Cutaneous metastasis of renal cell carcinoma. Am J Clin Dermatol; 2006;7(4):271-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cutaneous metastasis of renal cell carcinoma.
  • [MeSH-major] Carcinoma, Renal Cell / pathology. Head and Neck Neoplasms / secondary. Kidney Neoplasms / pathology. Skin Neoplasms / secondary


72. Madersbacher S, Ponholzer A, Franz K, Höltl W: [Synchronous bilateral renal cell cancer with a single ovarian metastasis and a fibromuscular dysplasia of the renal artery]. Aktuelle Urol; 2007 Jan;38(1):52-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Synchronous bilateral renal cell cancer with a single ovarian metastasis and a fibromuscular dysplasia of the renal artery].
  • [Transliterated title] Synchroner bilateraler Nierentumor mit singulärer Ovarialmetastase und fibromuskulärer Dysplasie der Nierenarterie.
  • INTRODUCTION: Ovarian metastases of renal cell cancer (RCC) are extremely rare with less than 20 cases reported to date.
  • These metastases occur in the majority of cases metachronous (i. e. prior to or after identification of the primary tumour) or--such as in our case--synchronous.
  • CASE REPORT: A 42-year-old women was diagnosed for synchronous bilateral renal and a left-sided ovarian mass.
  • In a first surgical step, the ovarian metastasis was removed laparoscopically and the 20 cm tumour on the right kidney via a transperitoneal tumour nephrectomy (histology: clear cell RCC, pT3bN0V1R0M1).
  • Prior to nephron-sparing surgery of the left kidney an angiography was performed revealing a massive fibromuscular dysplasia.
  • Under cold ischaemic perfusion, the two RCCs (pT1aV0R0) on the left side were excised and the renal artery replaced by a Goretex graft.
  • Two years after surgery the patient is recurrence-free and her renal function is normal.
  • CONCLUSION: Although extremely rare, the possibility of an ovarian metastasis should be considered in women with RCC.
  • The presented case was unique because of synchronous bilateral RCC, an ovarian metastasis and a fibromuscular dysplasia of the renal artery requiring a sophisticated surgical approach.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Fibromuscular Dysplasia / diagnosis. Kidney Neoplasms / diagnosis. Neoplasms, Multiple Primary / secondary. Ovarian Neoplasms / secondary. Renal Artery Obstruction / diagnosis
  • [MeSH-minor] Adult. Anastomosis, Surgical. Blood Vessel Prosthesis Implantation. Female. Humans. Laparoscopy. Neoplasm Staging. Nephrectomy. Postoperative Complications / diagnosis. Postoperative Complications / therapy. Stents


73. Oya M, Asakura H, Mizuno R, Marumo K, Murai M: Repeated regression of pulmonary metastases from renal cell carcinoma after treatment using different interferon-alpha preparations. Biomed Res; 2005 Jun;26(3):135-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Repeated regression of pulmonary metastases from renal cell carcinoma after treatment using different interferon-alpha preparations.
  • A 49-year-old man with pulmonary metastasis from renal cell carcinoma (RCC) was treated with recombinant IFN-alpha2b (Intron A).
  • [MeSH-major] Antineoplastic Agents / pharmacology. Carcinoma, Renal Cell / drug therapy. Interferon-alpha / pharmacology. Kidney Neoplasms / drug therapy. Lung Neoplasms / drug therapy

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16011307.001).
  • [ISSN] 0388-6107
  • [Journal-full-title] Biomedical research (Tokyo, Japan)
  • [ISO-abbreviation] Biomed. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Interferon-alpha
  •  go-up   go-down


74. Pahernik S, Ziegler S, Roos F, Melchior SW, Thüroff JW: Small renal tumors: correlation of clinical and pathological features with tumor size. J Urol; 2007 Aug;178(2):414-7; discussion 416-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Small renal tumors: correlation of clinical and pathological features with tumor size.
  • PURPOSE: We analyzed the association between tumor diameter and pathological stage, histological subtype, tumor grade and the incidence of metastases in renal cell carcinoma with a diameter of up to 4 cm (clinical stage T1a).
  • MATERIALS AND METHODS: We analyzed a consecutive series of 663 patients with renal tumors 4 cm or less who underwent surgery at our institution between 1990 and 2006.
  • After excluding 115 patients (17.3%) with benign tumors 548 with renal cell carcinoma were included in the study.
  • Tumor size on preoperative imaging was correlated with pathological stage, tumor grade, histological subtype and incidence of metastases at diagnosis.
  • For data analysis tumors were stratified by tumor diameter into 3 groups, including 2 cm--99 patients with tumors up to 2 cm, 3 cm--234 with tumors between 2.1 and 3.0 cm, and 4 cm--215 with tumors between 3.1 and 4.0 cm in diameter.
  • RESULTS: Median clinical diameter of renal cell carcinoma in the whole series was 2.93 cm (range 0.8 to 4.0).
  • Tumor stage was pT1a, pT1b and pT3 in 84.5%, 8.0% and 7.5% of cases, respectively.
  • Tumor grade was 1 to 3 in 24.5%, 65.0% and 10.6% of cases, respectively.
  • The renal cell carcinoma histological subtype was clear cell carcinoma in 77.9% of patients, papillary carcinoma in 15.3% and chromophobe carcinoma in 6.8%.
  • Advanced tumor stage (pT3) was found in 3.0%, 5.1% and 12.1% of the patients in the 2, 3 and 4 cm groups, respectively (p <0.05).
  • Metastases at diagnosis were found in 3.0%, 2.6% and 6.0% of the patients in the 2, 3 and 4 cm groups, respectively.
  • CONCLUSIONS: Negative prognostic features increase with tumor diameter and they are associated with even small tumors.
  • However, above a tumor size of 3.0 cm there is a sharp increase in the incidence of negative prognostic parameters.
  • New diagnostic tests are warranted to better stratify patients with respect to treatment aggressiveness for small incidental renal tumors.
  • [MeSH-major] Carcinoma, Renal Cell / pathology. Kidney Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Diagnosis, Differential. Diagnostic Imaging. Disease Progression. Female. Humans. Kidney / pathology. Male. Middle Aged. Neoplasm Staging. Nephrectomy. Prognosis. Statistics as Topic

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17561161.001).
  • [ISSN] 0022-5347
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


75. Shuch B, La Rochelle JC, Klatte T, Riggs SB, Liu W, Kabbinavar FF, Pantuck AJ, Belldegrun AS: Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival. Cancer; 2008 Oct 1;113(7):1641-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival.
  • BACKGROUND: Patients with renal cell carcinoma brain metastases (RCCBM) are frequently excluded from trials and to the authors' knowledge no guidelines currently exist regarding central nervous system (CNS) surveillance or treatment.
  • RESULTS: A total of 138 patients were identified with RCCBM, of whom 92% had clear cell RCC and 95% had synchronous extracranial metastases.
  • The median overall survival after a diagnosis of RCCBM was 10.7 months; the 1-year, 2-year, and 5-year survival rates were 48%, 30%, and 12%, respectively.
  • The initial number of tumors (>1 tumor) was found to be an independent predictor of CNS recurrence (hazards ratio of 3.72; P < .001).
  • CONCLUSIONS: Patients with metastatic RCC should undergo CNS screening to allow the identification of smaller lesions that are more amenable to treatment.
  • [MeSH-major] Brain Neoplasms / secondary. Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology
  • [MeSH-minor] Craniotomy. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Retrospective Studies. Survival Rate


76. Leroy X, Farine MO, Buob D, Wacrenier A, Copin MC: Diagnostic value of cytokeratin 7, CD10 and mesothelin in distinguishing ovarian clear cell carcinoma from metastasis of renal clear cell carcinoma. Histopathology; 2007 Dec;51(6):874-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnostic value of cytokeratin 7, CD10 and mesothelin in distinguishing ovarian clear cell carcinoma from metastasis of renal clear cell carcinoma.
  • [MeSH-major] Adenocarcinoma, Clear Cell / diagnosis. Biomarkers, Tumor / analysis. Carcinoma, Renal Cell / diagnosis. Kidney Neoplasms / diagnosis. Ovarian Neoplasms / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Female. GPI-Linked Proteins. Humans. Immunohistochemistry. Keratin-7 / metabolism. Membrane Glycoproteins / metabolism. Neprilysin / metabolism


77. Novellas S: [What is your diagnosis? Metachronous metastasis of renal adenocarcinoma]. J Radiol; 2007 Dec;88(12):1906-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [What is your diagnosis? Metachronous metastasis of renal adenocarcinoma].
  • [Transliterated title] Quel est votre diagnostic: Metastases metachrones d'un adenocarcinome renal.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology. Pancreatic Neoplasms / secondary

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18235355.001).
  • [ISSN] 0221-0363
  • [Journal-full-title] Journal de radiologie
  • [ISO-abbreviation] J Radiol
  • [Language] fre
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


78. Alacacioglu A, Solmaz D, Oztop I, Yilmaz U: Late pulmonary metastasis of renal cell carcinoma after nephrectomy. Saudi Med J; 2007 Feb;28(2):286-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Late pulmonary metastasis of renal cell carcinoma after nephrectomy.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Carcinoma, Renal Cell / surgery. Kidney Neoplasms / surgery. Lung Neoplasms / secondary. Lung Neoplasms / surgery. Neoplasm Recurrence, Local / pathology

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17268714.001).
  • [ISSN] 0379-5284
  • [Journal-full-title] Saudi medical journal
  • [ISO-abbreviation] Saudi Med J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Saudi Arabia
  • [Number-of-references] 5
  •  go-up   go-down


79. Kawahara N, Tomita K, Murakami H, Demura S, Satomi K, Atomi Y: Total en bloc spondylectomy and a greater omentum pedicle flap for a large bone and soft tissue defect: solitary lumbar metastasis from renal cell carcinoma. J Orthop Sci; 2009 Nov;14(6):830-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Total en bloc spondylectomy and a greater omentum pedicle flap for a large bone and soft tissue defect: solitary lumbar metastasis from renal cell carcinoma.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Carcinoma, Renal Cell / surgery. Lumbar Vertebrae / surgery. Orthopedic Procedures / methods. Spinal Neoplasms / secondary. Spinal Neoplasms / surgery
  • [MeSH-minor] Aged. Bone Nails. Humans. Kidney Neoplasms / pathology. Male. Omentum / surgery. Prosthesis Implantation

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19997834.001).
  • [ISSN] 1436-2023
  • [Journal-full-title] Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
  • [ISO-abbreviation] J Orthop Sci
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


80. Kai H, Yamagata K, Usui J, Shimizu Y, Hirayama A, Yoh K, Mase K, Hirayama K, Nagase S, Nagata M, Kawai K, Akaza H, Koyama A: Crescentic glomerulonephritis associated with renal cell carcinoma after cancer immunotherapy. J Nephrol; 2005 Jul-Aug;18(4):436-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Crescentic glomerulonephritis associated with renal cell carcinoma after cancer immunotherapy.
  • A 59 year-old woman showed rapidly progressive glomerulonephritis during immunotherapy for metastatic renal cell carcinoma.
  • She received unilateral nephrectomy and cytotoxic T lymphocyte (CTL) therapy for the treatment of retroperitoneal lymph node metastasis of renal cell carcinoma.
  • Her renal biopsy specimen revealed necrotizing and crescentic glomerulonephritis with immune complex deposition.
  • After 24 sessions of DFPP, her serum IgG was reduced from 3,942 mg/dL to 2,400 mg/dL, and proteinuria (from 9.0 g/day to 0.9 g/day) and renal function (serum creatinine; from 5.6 mg/dL to 2.2 mg/dL) also improved.
  • The autopsy sample of the kidney showed that most of the glomeruli were obsolescent, but immunoglobulin depositions were reduced and necrotizing lesions were diminished.
  • In the patients with RPGN associated with renal cell carcinoma, renal functional recovery has not been observed upon immunosuppressive treatment.
  • We also discuss previous reports of RPGN associated with renal cell carcinoma, or RPGN after cancer immunotherapy.
  • [MeSH-major] Carcinoma, Renal Cell / drug therapy. Glomerulonephritis / chemically induced. Immunologic Factors / adverse effects. Interferon-alpha / adverse effects. Kidney Neoplasms / drug therapy


81. Maeda H, Okabayashi T, Kobayashi M, Araki K, Kohsaki T, Nishimori I, Onishi S, Ito S, Ogawa Y, Okuda H, Shuin T: Emergency pancreatoduodenectomy for pancreatic metastasis from renal cell carcinoma in a patient with von Hippel-Lindau disease: a case report. Dig Dis Sci; 2006 Aug;51(8):1383-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Emergency pancreatoduodenectomy for pancreatic metastasis from renal cell carcinoma in a patient with von Hippel-Lindau disease: a case report.
  • [MeSH-major] Carcinoma, Renal Cell / surgery. Kidney Neoplasms / surgery. Pancreatic Neoplasms / surgery. Pancreaticoduodenectomy / methods. von Hippel-Lindau Disease / complications
  • [MeSH-minor] Diagnosis, Differential. Emergencies. Female. Humans. Middle Aged


82. Kopetz S, Jimenez C, Tu SM, Sharma P: Pulmonary arteriovenous fistula in a patient with renal cell carcinoma. Eur Respir J; 2007 Apr;29(4):813-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pulmonary arteriovenous fistula in a patient with renal cell carcinoma.
  • Arteriovenous (AV) fistulas are common in renal cell carcinoma.
  • Case reports have previously described symptomatic fistulas in primary renal cell tumour or, less commonly, bone metastases.
  • The current study describes a patient with lung metastases from renal cell carcinoma who developed a symptomatic pulmonary AV fistula.
  • Supporting radiographs include a unique ventilation-perfusion finding of perfusion tracer in the kidney that is diagnostic of a pulmonary shunt.
  • This is the first report of a pulmonary fistula from renal cell carcinoma.
  • This rare complication of renal cell carcinoma reflects its diverse clinical presentations and unique tumour biology.
  • [MeSH-major] Arteriovenous Fistula / diagnosis. Carcinoma, Renal Cell / diagnosis. Kidney Neoplasms / diagnosis. Lung Diseases / diagnosis
  • [MeSH-minor] Aged. Angiography. Female. Humans. Lung / pathology. Lung Neoplasms / secondary. Neoplasm Metastasis. Perfusion. Tomography, X-Ray Computed


83. Lin CM, Sun GH, Lee SS, Yu DS, Chang SY, Wu ST: Remote metastatic cervical carcinoma to kidneys mimicking bilateral renal abscesses. Eur J Cancer Care (Engl); 2007 Nov;16(6):526-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Remote metastatic cervical carcinoma to kidneys mimicking bilateral renal abscesses.
  • A 53-year-old woman presented bilateral renal masses, which were interpreted as abscesses with a computed tomography scan 9 years after primary surgery for cervical carcinoma.
  • Subsequent biopsies under ultrasound guidance revealed metastatic adenocarcinoma of kidneys originating from the cervical carcinoma.
  • Clinical detection of renal involvement from cervical cancer is extremely rare.
  • In comparison with these cases, the time between renal metastases and initial detection of cervical carcinoma is the longest in our case.
  • [MeSH-major] Adenocarcinoma / secondary. Kidney Neoplasms / secondary. Uterine Cervical Neoplasms / pathology
  • [MeSH-minor] Abscess / diagnosis. Biomarkers, Tumor / analysis. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Keratin-7 / analysis. Kidney Diseases / diagnosis. Middle Aged. Tomography, X-Ray Computed


84. Francia G, Emmenegger U, Lee CR, Shaked Y, Folkins C, Mossoba M, Medin JA, Man S, Zhu Z, Witte L, Kerbel RS: Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using beta-human choriogonadotropin secreting tumor cell lines. Mol Cancer Ther; 2008 Oct;7(10):3452-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Long-term progression and therapeutic response of visceral metastatic disease non-invasively monitored in mouse urine using beta-human choriogonadotropin secreting tumor cell lines.
  • Historically, the use of mouse models of metastatic disease to evaluate anticancer therapies has been hampered because of difficulties in detection and quantification of such lesions without sacrificing the mice, which in turn may also be dictated by institutional or ethical guidelines.
  • A new method to non-invasively measure tumor burden, as yet untested to monitor spontaneous metastases, is the use of transplanted tumors expressing secretable human beta-chorionic gonadotropin (beta-hCG) that can be measured in urine.
  • We describe examples of beta-hCG-transfected tumor cell lines for evaluating the effect of different therapies on metastatic disease, which in some cases involved monitoring tumor growth for >100 days.
  • We used beta-hCG-tagged mouse B16 melanoma and erbB-2/Her-2-expressing human breast cancer MDA-MB-231 models, and drug treatments included metronomic low-dose cyclophosphamide chemotherapy with or without a vascular endothelial growth factor receptor 2-targeting antibody (DC101) or trastuzumab, the erbB-2/Her-2-targeting antibody.
  • Both experimental and spontaneous metastasis models were studied; in the latter case, an increase in urine beta-hCG always foreshadowed the development of lung, liver, brain, and kidney metastases.
  • Metastatic disease was unresponsive to DC101 or trastuzumab monotherapy treatment, as assessed by beta-hCG levels.
  • Our results also suggest that beta-hCG levels may be set as an end point for metastasis studies, circumventing guidelines, which have often hampered the use of advanced disease models.
  • Collectively, our data indicates that beta-hCG is an effective noninvasive preclinical marker for the long term monitoring of untreated or treated metastatic disease.
  • [MeSH-major] Chorionic Gonadotropin, beta Subunit, Human / urine. Neoplasm Metastasis / pathology. Neoplasm Metastasis / therapy. Viscera / pathology
  • [MeSH-minor] Angiogenesis Inhibitors / administration & dosage. Angiogenesis Inhibitors / pharmacology. Animals. Cell Line, Tumor. Cell Proliferation / drug effects. Cyclophosphamide / administration & dosage. Cyclophosphamide / pharmacology. Disease Progression. Female. Humans. Melanoma, Experimental / pathology. Mice. Mice, SCID. Receptor, ErbB-2 / metabolism. Time Factors

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18852148.001).
  • [ISSN] 1535-7163
  • [Journal-full-title] Molecular cancer therapeutics
  • [ISO-abbreviation] Mol. Cancer Ther.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA-41233
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Chorionic Gonadotropin, beta Subunit, Human; 8N3DW7272P / Cyclophosphamide; EC 2.7.10.1 / Receptor, ErbB-2
  •  go-up   go-down


85. Kumar A, Nadig M, Patra V, Srivastava DN, Verma K, Bal CS: Adrenal and renal metastases from follicular thyroid cancer. Br J Radiol; 2005 Nov;78(935):1038-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adrenal and renal metastases from follicular thyroid cancer.
  • Patients with differentiated thyroid cancer may have asymptomatic involvement of renal and/or adrenal gland, particularly if they are elderly and have associated metastases to other organs, which may remain undetected if these patients are not subjected to radioiodine treatment.
  • [MeSH-major] Adenocarcinoma, Follicular / secondary. Adrenal Gland Neoplasms / secondary. Kidney Neoplasms / secondary. Thyroid Neoplasms / surgery


86. Roviello F, Caruso S, Moscovita Falzarano S, Marrelli D, Neri A, Rampone B, De Marco G, Perrotta ME, Mariani F: Small bowel metastases from renal cell carcinoma: a rare cause of intestinal intussusception. J Nephrol; 2006 Mar-Apr;19(2):234-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Small bowel metastases from renal cell carcinoma: a rare cause of intestinal intussusception.
  • Small bowel metastases from renal cell carcinoma (RCC) are very rare.
  • We report a case of a 48-year-old female presenting a jejunal intussusception due to intestinal metastasis from RCC.
  • However, if considered in the total summary of reported cases with small bowel metastases from RCC, intussusception is a probable cause.
  • [MeSH-major] Carcinoma, Renal Cell / radiography. Intussusception / radiography. Jejunal Neoplasms / radiography. Kidney Neoplasms / radiography
  • [MeSH-minor] Female. Humans. Male. Middle Aged. Neoplasm Metastasis

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Intestinal Cancer.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16736429.001).
  • [ISSN] 1121-8428
  • [Journal-full-title] Journal of nephrology
  • [ISO-abbreviation] J. Nephrol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Italy
  • [Number-of-references] 32
  •  go-up   go-down


87. Zografos GN, Farfaras A, Aggeli C, Kontogeorgos G, Pagoni M, Vogiati S, Vasiliadis G, Papastratis G: Laparoscopic adrenalectomy for large adrenal metastasis from contralateral renal cell carcinoma. JSLS; 2007 Apr-Jun;11(2):261-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Laparoscopic adrenalectomy for large adrenal metastasis from contralateral renal cell carcinoma.
  • We present herein the case of a patient with solitary metachronous contralateral adrenal metastasis from renal cell cancer.
  • The patient had undergone left radical nephrectomy and adrenalectomy for localized renal cancer 7 years previously.
  • Histology showed right adrenal metastasis from renal cancer.


88. Matsutani T, Sasajima K, Miyamoto M, Yokoyama T, Maruyama H, Yanagi K, Matsuda A, Kashiwabara M, Suzuki S, Tajiri T: Resection of pancreatic metastasis from renal cell carcinoma and an early gastric cancer. J Nippon Med Sch; 2008 Feb;75(1):41-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Resection of pancreatic metastasis from renal cell carcinoma and an early gastric cancer.
  • An 81-year-old woman, who had undergone left radical nephrectomy for renal cell carcinoma 17 years previously, was found to have a mass approximately 5cm in diameter in the body of the pancreas and an early gastric cancer.
  • The patient was suspected of having pancreatic metastasis from renal cell carcinoma and an early gastric cancer and underwent distal pancreatectomy, splenectomy, and distal gastrectomy.
  • Histologic examination showed that the pancreatic tumor was a clear cell renal cell carcinoma that had metastasized to the body of the pancreas and that the gastric cancer was a well-differentiated adenocarcinoma that had invaded the mucosa.
  • Renal cell carcinoma metastatic to the pancreas with gastric cancer rarely occurs, and surgical resection might have improved the quality of life in this patient.
  • Careful long-term follow-up is necessary for patients who have undergone surgery for renal cell carcinoma.
  • [MeSH-major] Adenocarcinoma / surgery. Carcinoma, Renal Cell / secondary. Carcinoma, Renal Cell / surgery. Kidney Neoplasms / pathology. Neoplasms, Multiple Primary. Pancreatic Neoplasms / secondary. Pancreatic Neoplasms / surgery. Stomach Neoplasms / surgery
  • [MeSH-minor] Aged, 80 and over. Digestive System Surgical Procedures. Female. Follow-Up Studies. Humans. Neoplasm Staging. Nephrectomy. Quality of Life. Splenectomy. Treatment Outcome


89. Ulmar B, Naumann U, Catalkaya S, Muche R, Cakir B, Schmidt R, Reichel H, Huch K: Prognosis scores of Tokuhashi and Tomita for patients with spinal metastases of renal cancer. Ann Surg Oncol; 2007 Feb;14(2):998-1004
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognosis scores of Tokuhashi and Tomita for patients with spinal metastases of renal cancer.
  • BACKGROUND: Retrospective evaluation of the prognosis scores of Tokuhashi and Tomita for life expectancy in 37 consecutive patients with spinal metastases secondary to renal cancer who underwent surgery.
  • The score of Tokuhashi, composed of six parameters, each rated from zero to two, has been proposed in 1990 for the prognostic assessment of patients with spinal metastases.
  • In 2001, Tomita et al. created another prognostic score, composed of three parameters, growth behaviour of the primary tumor (slow, moderate and rapid) and the evidence of visceral and bony metastases.
  • METHODS: Thirty-seven patients, surgically treated for vertebral metastases secondary to renal cancer were studied.
  • RESULTS: Applying the Tokuhashi Score for the estimation of life expectancy of renal cancer patients with vertebral metastases was found to provide very reliable results with a statistically high significance.
  • CONCLUSION: For surgical decisions in renal cancer patients with spinal metastases, the prognostic score of Tokuhashi appears to be much more valuable than the Tomita score.
  • [MeSH-major] Carcinoma, Renal Cell / surgery. Kidney Neoplasms / pathology. Severity of Illness Index. Spinal Neoplasms / surgery

  • Genetic Alliance. consumer health - Kidney cancer.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17083006.001).
  • [ISSN] 1068-9265
  • [Journal-full-title] Annals of surgical oncology
  • [ISO-abbreviation] Ann. Surg. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


90. Ninan S, Jain PK, Paul A, Menon KV: Synchronous pancreatic metastases from asymptomatic renal cell carcinoma. JOP; 2005 Jan;6(1):26-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous pancreatic metastases from asymptomatic renal cell carcinoma.
  • CONTEXT: Pancreatic involvement from metastatic renal cell carcinoma accounts for 0.25-3% of the cases.
  • The distinction between primary pancreatic clear cell tumour and metastatic deposits from renal cell carcinoma may lead to diagnostic difficulties.
  • Usually metastasis from renal cell carcinoma presents many years after the primary tumour has been resected.
  • A typical metastatic lesion in pancreas is seen as hyper-vascular lesion on CT scan.
  • CASE REPORT: We report herein the case of a patient with a solitary pancreatic metastatic head lesion from renal cell carcinoma was successfully resected before asymptomatic primary could be identified.
  • CONCLUSIONS: Early identification of pancreatic metastasis from renal cell carcinoma is possible with characteristic appearance on radiological imaging and surgical resection of the metastasis provides better results.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology. Pancreatic Neoplasms / secondary


91. Ruggiero FP, Frauenhoffer EE, Stack BC Jr: Papillary thyroid cancer with an initial presentation of abdominal and flank pain. Am J Otolaryngol; 2005 Mar-Apr;26(2):142-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Papillary thyroid cancer with an initial presentation of abdominal and flank pain.
  • PURPOSE: Well-differentiated thyroid cancer typically presents as a thyroid mass.
  • Common sites of metastases upon presentation include cervical lymph nodes, lung, and bone.
  • Well-differentiated thyroid cancer with clinically apparent kidney metastases is rare, with fewer than 20 cases reported in the literature.
  • In the vast majority of these cases, the patients had known thyroid neoplasms at the time the renal metastases were identified.
  • RESULTS: The patient underwent radical nephrectomy for a right renal mass, which was diagnosed as papillary thyroid carcinoma follicular variant.
  • During subsequent evaluation, metastatic disease was also identified in the patient's lungs.
  • CONCLUSIONS: Papillary cancer, which ordinarily behaves in an indolent manner, can have unusual presentation, including disseminated metastasis on presentation.
  • Renal metastases are extremely rare.
  • [MeSH-major] Abdominal Pain / diagnosis. Abdominal Pain / etiology. Carcinoma, Papillary / pathology. Carcinoma, Papillary / radiography. Flank Pain / diagnosis. Thyroid Neoplasms / pathology. Thyroid Neoplasms / radiography
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Kidney Neoplasms / pathology. Kidney Neoplasms / surgery. Magnetic Resonance Imaging. Neoplasms, Second Primary. Nephrectomy. Radiosurgery. Tomography, X-Ray Computed


92. Vidart A, Fehri K, Pfister C: [Unusual metastasis of renal carcinoma]. Ann Urol (Paris); 2006 Aug;40(4):211-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Unusual metastasis of renal carcinoma].
  • [Transliterated title] Metastases inhabituelles du cancer du rein.
  • Renal carcinoma, the third most common urological cancer, induces presence of metastases in 75% of cases.
  • The most affected sites for metastasis are the lungs, the lymphatic system, bones, the liver, adrenal glands and the brain with sometimes a cancer free period of several years prior to evolutionary recurrence of the disease.
  • The aim of this literature review is to report on secondary uncommon renal localizations by underlining their clinical significance, as well as main characteristics, in order to provide guidelines for effective patient diagnosis and therapeutic management.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology
  • [MeSH-minor] Adrenal Gland Neoplasms / secondary. Bone Neoplasms / secondary. Brain Neoplasms / secondary. Humans. Liver Neoplasms / secondary. Lung Neoplasms / secondary. Lymphatic Vessel Tumors / secondary. Prognosis

  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16970064.001).
  • [ISSN] 0003-4401
  • [Journal-full-title] Annales d'urologie
  • [ISO-abbreviation] Ann Urol (Paris)
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 124
  •  go-up   go-down


93. Gopan T, Toms SA, Prayson RA, Suh JH, Hamrahian AH, Weil RJ: Symptomatic pituitary metastases from renal cell carcinoma. Pituitary; 2007;10(3):251-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Symptomatic pituitary metastases from renal cell carcinoma.
  • Symptomatic metastases to the pituitary (MP) from renal cell carcinoma (RCC) are rare.
  • RCC was diagnosed a median of 11 years prior to diagnosis of MP (range 0-27 years).
  • Four patients had previously developed distant metastases.
  • Four patients are alive (follow up 6-46 months); 1 patient died due to systemic metastases at 12 months.
  • Metastases to the pituitary from RCC cause more severe hypopituitarism and visual dysfunction compared to those from other primaries, whereas DI is less common.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology. Pituitary Neoplasms / secondary

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. HYDROCORTISONE .
  • Hazardous Substances Data Bank. LEVOTHYROXINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiat Med. 1996 Mar-Apr;14(2):71-6 [8776768.001]
  • [Cites] Oncology. 1973;27(6):533-42 [4355105.001]
  • [Cites] Endocr Pract. 1998 Jul-Aug;4(4):204-7 [15251735.001]
  • [Cites] J Clin Endocrinol Metab. 1987 Sep;65(3):469-74 [3624409.001]
  • [Cites] Cancer. 1970 Sep;26(3):656-9 [5272295.001]
  • [Cites] Arch Otorhinolaryngol. 1981;232(3):227-32 [7305726.001]
  • [Cites] J Urol. 1993 Apr;149(4):821-2; discussion 823 [8455249.001]
  • [Cites] Nat Med. 2006 Aug;12(8):895-904 [16892035.001]
  • [Cites] N Engl J Med. 2007 Jan 11;356(2):115-24 [17215529.001]
  • [Cites] Neurol Med Chir (Tokyo). 2004 Jan;44(1):47-52 [14959938.001]
  • [Cites] Neurosurg Focus. 2004 Apr 15;16(4):E8 [15191337.001]
  • [Cites] Br J Neurosurg. 1989;3(1):71-9 [2789715.001]
  • [Cites] Ann Clin Biochem. 1998 Jul;35 ( Pt 4):542-4 [9681058.001]
  • [Cites] N Engl J Med. 2007 Jan 11;356(2):125-34 [17215530.001]
  • [Cites] J Endocrinol Invest. 1992 Oct;15(9):677-81 [1479150.001]
  • [Cites] Neurol Med Chir (Tokyo). 1988 Jan;28(1):78-82 [2455248.001]
  • [Cites] J Urol. 1985 Jul;134(1):128-30 [4009805.001]
  • [Cites] J Neurosurg. 1998 Jul;89(1):69-73 [9647174.001]
  • [Cites] Neurology. 1981 Aug;31(8):998-1002 [7196526.001]
  • [Cites] Surg Neurol. 1983 Nov;20(5):373-8 [6635925.001]
  • [Cites] J Comput Assist Tomogr. 1993 May-Jun;17(3):432-7 [8491906.001]
  • [Cites] Neurol Med Chir (Tokyo). 2005 Aug;45(8):418-22 [16127262.001]
  • [Cites] J Endocrinol Invest. 2004 May;27(5):471-4 [15279082.001]
  • [Cites] Acta Neurochir (Wien). 2003 Mar;145(3):227-31 [12632120.001]
  • [Cites] Neurosurg Rev. 1992;15(4):319-22 [1480281.001]
  • [Cites] Cancer. 1975 Jul;36(1):216-20 [1203849.001]
  • [Cites] Am J Med. 1984 Feb;76(2):337-40 [6695956.001]
  • [Cites] Am J Pathol. 1984 Jan;114(1):131-6 [6140849.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Feb;89(2):574-80 [14764764.001]
  • [Cites] Arch Neurol. 2002 Dec;59(12):1962-3 [12470187.001]
  • [Cites] Acta Neurochir (Wien). 2005 Sep;147(9):1003-4; discussion 1004 [16041465.001]
  • [Cites] Neurochirurgia (Stuttg). 1990 Jul;33(4):127-31 [2203980.001]
  • (PMID = 17541748.001).
  • [ISSN] 1386-341X
  • [Journal-full-title] Pituitary
  • [ISO-abbreviation] Pituitary
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Hormones; ENR1LLB0FP / Deamino Arginine Vasopressin; Q51BO43MG4 / Thyroxine; WI4X0X7BPJ / Hydrocortisone
  •  go-up   go-down


94. Kim ES, Chang JH, Choi HS, Kim J, Lee SK: Diagnostic yield of double-dose gadobutrol in the detection of brain metastasis: intraindividual comparison with double-dose gadopentetate dimeglumine. AJNR Am J Neuroradiol; 2010 Jun;31(6):1055-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnostic yield of double-dose gadobutrol in the detection of brain metastasis: intraindividual comparison with double-dose gadopentetate dimeglumine.
  • BACKGROUND AND PURPOSE: Accurate assessment of the number and lesion characteristics of brain metastasis is very important in GKS.
  • The purpose of this study was to compare the diagnostic efficacy of DD gadobutrol in the detection of brain metastases compared with a DD 0.5-mol/L gadolinium contrast, gadopentetate dimeglumine.
  • MATERIALS AND METHODS: Records of 27 patients (male to female ratio, 15:12; mean age, 57.1 years) diagnosed with brain metastasis and having undergone GKS were retrospectively analyzed.
  • The second MR imaging with a DD of gadobutrol was performed during GKS by using the same parameters used for the first scan.
  • Only 2 cases showed lower CNR on DD gadobutrol images: 1 with hemorrhagic metastasis from renal cell carcinoma and the other with steroid treatment after the first MR imaging.
  • CONCLUSIONS: DD 1.0-mol/L gadobutrol provides higher lesion conspicuity and enhances lesion detection in brain metastasis compared with DD 0.5-mol/L gadolinium contrast agents.
  • [MeSH-major] Brain Neoplasms / secondary. Carcinoma, Renal Cell / secondary. Contrast Media. Gadolinium DTPA. Magnetic Resonance Imaging / methods. Organometallic Compounds
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Humans. Kidney Neoplasms / pathology. Lung Neoplasms / pathology. Male. Middle Aged. Retrospective Studies. Young Adult

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20110372.001).
  • [ISSN] 1936-959X
  • [Journal-full-title] AJNR. American journal of neuroradiology
  • [ISO-abbreviation] AJNR Am J Neuroradiol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; 0 / Organometallic Compounds; 1BJ477IO2L / gadobutrol; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


95. Bandi G, Wen CC, Moon TD, Nakada SY: Single center preliminary experience with hand-assisted laparoscopic resection of isolated renal cell carcinoma fossa recurrences. Urology; 2008 Mar;71(3):495-9; discussion 499-500
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Single center preliminary experience with hand-assisted laparoscopic resection of isolated renal cell carcinoma fossa recurrences.
  • OBJECTIVES: Solitary metastasis to the renal fossa after radical nephrectomy for renal cell carcinoma is uncommon.
  • We report the first series on hand-assisted laparoscopic excision for renal cell carcinoma fossa recurrences.
  • METHODS: We performed a retrospective review of patients who underwent hand-assisted laparoscopic excision of renal cell carcinoma fossa recurrence.
  • Patients with distant metastasis or local lymph node or adrenal metastasis were excluded from analysis.
  • We collected data on patient and tumor characteristics, nephrectomy and fossa mass excision procedures, and postoperative outcomes.
  • RESULTS: Between 2001 and 2007, 5 patients underwent laparoscopic resection of a renal fossa recurrence.
  • Mean time to recurrence after radical nephrectomy was 23 months (range, 5 to 46 months) and mean size of the renal fossa mass was 6 cm (range, 4.2 to 9.5 cm).
  • With mean follow-up of 43 months, the cancer-specific and disease-free survival rates were 60% and 20%, respectively.
  • Of the 4 patients who underwent complete resection, 2 died from metastatic disease at 13 and 56 months, 1 continues to have progressive metastatic disease at 69 months, and 1 remains free of any clinical evidence of metastatic disease or recurrence at 37 months.
  • One patient who underwent incomplete resection as a result of inferior vena cava invasion continues to have progressive local and distant metastatic disease at 40-month follow-up.
  • CONCLUSIONS: Hand-assisted laparoscopic excision of renal fossa recurrence after radical nephrectomy appears to be safe and effective for carefully selected patients.
  • [MeSH-major] Carcinoma, Renal Cell / surgery. Kidney Neoplasms / surgery. Laparoscopy / methods. Neoplasm Recurrence, Local / surgery. Nephrectomy

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18342195.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


96. Bluemke K, Bilkenroth U, Meye A, Fuessel S, Lautenschlaeger C, Goebel S, Melchior A, Heynemann H, Fornara P, Taubert H: Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis. Cancer Epidemiol Biomarkers Prev; 2009 Aug;18(8):2190-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Detection of circulating tumor cells in peripheral blood of patients with renal cell carcinoma correlates with prognosis.
  • PURPOSE: The aim of this study was to evaluate the clinical relevance of the presence of disseminated tumor cells in peripheral blood (so-called circulating tumor cells) for renal cell carcinoma patients.
  • METHODS: Two hundred thirty-three peripheral blood samples from 154 renal cell carcinoma patients were investigated for the presence of disseminated tumor cells by autoMACS technique and immunocytochemical staining of cytokeratin.
  • The frequency of circulating tumor cells was analyzed statistically for correlation with relevant clinical data.
  • RESULTS: Two kinds of tumor cells were detected: those with expression of cytokeratin 8/18 (CK+) and cells without a detectable cytokeratin expression, which we called large blue-stained cells with a tumorlike morphology.
  • After following the CD45 autoMACS depletion protocol, we identified circulating tumor cells in 96 (41%) of 233 peripheral blood samples, which originated from 81 (53%) of 154 renal cell carcinoma patients.
  • A significant correlation between the detection of circulating tumor cells and positive lymph node status (P < 0.001; chi(2) test) and the presence of synchronous metastases at the time of primary tumor resection (P = 0.014; chi(2) test) was found.
  • In a multivariate Cox's regression hazard model, presence of CK+ circulating tumor cells was significantly correlated with poor overall survival for renal cell carcinoma patients (relative risk, 2.3; P = 0.048).
  • CONCLUSIONS: The presence of circulating tumor cells correlated to lymph node status and presence of synchronous metastases in renal cell carcinoma.
  • It is important to evaluate CK+ and blue-stained tumor cells together to determine the role of circulating tumor cells in tumor behavior and disease progression.
  • Detection of CK+ circulating tumor cells in peripheral blood is a significant and independent prognostic factor for renal cell carcinoma.
  • [MeSH-major] Biomarkers, Tumor / blood. Carcinoma, Renal Cell / blood. Kidney Neoplasms / blood. Neoplastic Cells, Circulating / pathology
  • [MeSH-minor] Flow Cytometry. Humans. Immunohistochemistry. Kaplan-Meier Estimate. Keratin-18 / metabolism. Keratin-8 / metabolism. Lymphatic Metastasis / pathology. Neoplasm Metastasis / pathology. Prognosis

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19661076.001).
  • [ISSN] 1538-7755
  • [Journal-full-title] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • [ISO-abbreviation] Cancer Epidemiol. Biomarkers Prev.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Keratin-18; 0 / Keratin-8
  •  go-up   go-down


97. Simon JP, Bellemans J, Samson I: Metastasis from renal cell carcinoma presenting as osteolysis in total hip arthroplasty: a case report. Acta Orthop Belg; 2008 Feb;74(1):122-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasis from renal cell carcinoma presenting as osteolysis in total hip arthroplasty: a case report.
  • We report a case of a pelvic metastasis from a renal carcinoma in association with a total hip arthroplasty.
  • [MeSH-major] Arthroplasty, Replacement, Hip. Bone Neoplasms / secondary. Carcinoma, Renal Cell / pathology. Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology. Osteolysis / etiology. Pelvic Bones


98. Mechó S, Quiroga S, Cuéllar H, Sebastià C: Pancreatic metastasis of renal cell carcinoma: multidetector CT findings. Abdom Imaging; 2009 May-Jun;34(3):385-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pancreatic metastasis of renal cell carcinoma: multidetector CT findings.
  • Pancreatic metastasis of renal cell carcinoma is more prevalent than the rates reported in the literature before the development of multidetector computed tomography (MDCT).
  • In this article we review the MDCT features of four cases of pancreatic metastasis of renal cell carcinoma to familiarize radiologists with this entity and the most suitable study method for its detection.
  • [MeSH-major] Carcinoma, Renal Cell / pathology. Kidney Neoplasms / pathology. Pancreatic Neoplasms / radiography. Pancreatic Neoplasms / secondary
  • [MeSH-minor] Aged. Aged, 80 and over. Contrast Media. Female. Humans. Kidney / radiography. Male. Middle Aged. Pancreas / radiography. Radiographic Image Enhancement / methods. Retrospective Studies. Tomography, X-Ray Computed / methods

  • Genetic Alliance. consumer health - Renal cell carcinoma.
  • MedlinePlus Health Information. consumer health - Kidney Cancer.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18404285.001).
  • [ISSN] 1432-0509
  • [Journal-full-title] Abdominal imaging
  • [ISO-abbreviation] Abdom Imaging
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media
  •  go-up   go-down


99. Deguchi Y, Shimada K, Nara S, Esaki M, Sakamoto Y, Kosuge T, Hiraoka N: Pancreaticojejunostomy with invagination of the punched pancreatic remnant after medial pancreatectomy and enucleation for multiple metastases of renal cell carcinoma: report of a case. Surg Today; 2009;39(12):1086-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pancreaticojejunostomy with invagination of the punched pancreatic remnant after medial pancreatectomy and enucleation for multiple metastases of renal cell carcinoma: report of a case.
  • We report the successful resection of multiple pancreatic metastases of renal cell carcinoma (RCC), achieved by performing medial pancreatectomy and enucleation, preserving as much of the pancreatic parenchyma as possible.
  • Considering the unusual behavior of RCC metastasis and the difficulty in predicting the pattern of recurrence, we should devise the optimal surgical strategy to provide cancer-free surgical margins and preserve as much of the pancreatic parenchyma as possible.
  • [MeSH-major] Carcinoma, Renal Cell / secondary. Kidney Neoplasms / pathology. Neoplasm Invasiveness / pathology. Pancreatic Neoplasms / secondary. Pancreatic Neoplasms / surgery. Pancreaticojejunostomy / methods
  • [MeSH-minor] Biopsy, Needle. Follow-Up Studies. Humans. Immunohistochemistry. Male. Middle Aged. Monitoring, Intraoperative / methods. Neoplasm Staging. Nephrectomy / methods. Risk Assessment. Tomography, X-Ray Computed. Treatment Outcome. Ultrasonography, Doppler


100. Kwok Y, Patchell RA: Commentary (Kwok/Patchell): Radiation Therapy in the Management of Brain Metastases From Renal Cell Carcinoma. Oncology (Williston Park); 2006 May 01;20(6)
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Commentary (Kwok/Patchell): Radiation Therapy in the Management of Brain Metastases From Renal Cell Carcinoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28326511.001).
  • [ISSN] 0890-9091
  • [Journal-full-title] Oncology (Williston Park, N.Y.)
  • [ISO-abbreviation] Oncology (Williston Park, N.Y.)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down






Advertisement